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RESUMEN 	  	  
Los virus de ARN son probablemente algunos de los 
parásitos más extendidos que se pueden encontrar en todas las 
formas de vida. Estos agentes infecciosos parecen 
particularmente propensos a causar enfermedades emergentes 
en plantas, seres humanos y otros animales. Sus habilidades 
para escapar al sistema inmune, evadir estrategias antivirales o 
para infectar a nuevas especies son una consecuencia directa de 
su enorme capacidad para evolucionar rápidamente. 
Comprender los procesos básicos del cambio evolutivo puede 
ser unos de los principales pasos necesarios en el diseño de 
nuevas estrategias de intervención. 
Desde una perspectiva evolutiva, una de las principales 
características de los virus de ARN es su capacidad para mutar. 
El conocimiento de las tasas de mutación y el espectro 
molecular de mutaciones espontáneas son importantes para 
entender la evolución de la composición genética de las 
poblaciones virales. Estudios anteriores han demostrado que la 
tasa de mutaciones espontáneas de los virus de ARN varía 
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ampliamente entre 0.01 y 2 mutaciones por genoma y 
generación, ocupando los virus de plantas la parte inferior de 
esta escala de valores. 
En este estudio, se propuso analizar el espectro 
mutacional y la tasa de mutación del virus del grabado del tabaco 
(Tobacco etch virus, TEV), como modelo para los virus de ARN 
de cadena positiva. Nuestro experimento minimiza la acción 
purificadora de la selección en el espectro mutacional, dando 
así una imagen exacta de qué tipo de mutación ha producido la 
replicasa viral. Hemos calculado la tasa de mutación 
espontánea de este virus, hallándose en el intervalo de valores 
entre 10-6 - 10-5 mutaciones por sitio y generación. Nuestras 
estimaciones se encuentran en el mismo rango de valores que 
los anteriormente descritos para otros virus ARN de plantas.  
La recombinación de un virus de ARN es un parámetro 
evolutivo que contribuye significativamente a la diversidad y a 
la evolución de los virus. La tasa de recombinación depende de 
dos parámetros: de la frecuencia de intercambio genético entre 
genomas virales dentro de una célula infectada del huésped y 
de la frecuencia de las células doblemente-infectadas. A pesar 
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de la importancia del conocimiento de dichos factores, 
actualmente solo se ha estimado experimentalmente la tasa de 
recombinación del retrovirus virus del mosaico de la coliflor 
(Cauliflower mosaic virus, CaMV) (Froissart et al., 2005), mediante 
una cuantificación in vivo y directa de la tasa de recombinación 
de dicho virus durante la infección de un huésped. Dicha tasa 
se estimó en 4×10-5 eventos de recombinación por nucleótido y 
por ciclo de replicación.  
En los potyvirus, observaciones in vivo han demostrado 
que aislados del mismo virus se segregan espacialmente 
durante infecciones mixtas. Esta segregación debería reducir al 
mínimo la posibilidad de dos genotipos de infectar las mismas 
células y así limitar eventos de recombinación durante la 
replicación del ARN viral. Para conciliar estas observaciones, 
hemos evaluado la tasa de recombinación y la multiplicidad de 
infección (MOI) del virus TEV, in vivo. La tasa de 
recombinación se estimó en 1.03×10-5 eventos de recombinación 
por nucleótido y generación. Este valor se encuentra en el 
mismo orden de magnitud que la tasa de mutación del TEV, lo 
que sugiere que la recombinación tiene una importancia 
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comparable a la mutación puntual en la creación de 
variabilidad. La multiplicidad de infección celular se define 
como el número de genomas virales que logran infectar de 
manera eficaz una célula. Dos estudios recientes han mostrado 
estimaciones in vivo de la MOI para el virus del mosaico del tabaco 
(Tobacco mosaic virus, TMV) y del CaMV, gracias a métodos 
sofisticados que miden la distribución de dos genotipos virales 
en las células del huésped. 
Aquí presentamos un análisis detallado de la dinámica 
temporal y espacial de la MOI celular durante la colonización 
de una planta por el TEV. Observamos una baja frecuencia 
tanto del número de células infectadas por el virus (media ± 
SD: 0.100 ± 0.073), como de las infectadas por dos genotipos del 
TEV (media ± SD: 0.012 ± 0.023). Se usó un nuevo método 
basado en un modelo de selección para determinar la MOI. Los 
valores de MOI predichos fueron bajos, oscilando entre 1.0 
(hoja tres, 3 días después de la inoculación (dpi)) a 1.6 (hoja 
cuatro, 7 dpi). 
Por último, la alta diversidad genética de las 
poblaciones virales da lugar a una nube de variantes, todas 
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vinculadas a través de mutación, que interactúan y contribuyen 
colectivamente, conocido también por el término de 
cuasiespecies. Las poblaciones virales pueden adaptarse 
rápidamente a sus entornos dinámicos, y son notablemente 
inestables en determinadas condiciones como hemos 
demostrado en este trabajo durante la evolución del TEV en el 
caso de redundancia genética y funcional. Después de varios 
pasos a tiempos largos de infección en plantas transgénicas que 
expresan la replicasa viral NIb, se observaron grandes 
deleciones y múltiples partículas defectuosas. Este resultado 
demuestra la gran plasticidad del genoma de los virus ARN y 
su capacidad para eliminar cualquier carga genética 
innecesaria. 
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ABSTRACT 	  	  
RNA viruses are probably some of the most pervasive 
parasites that can be found in all life forms. These infectious 
agents seem particularly prone to causing emerging diseases in 
plants, humans and other animals. Their abilities to escape the 
immune system, evade antiviral strategies or to jump to new 
species are a direct consequence of their enormous capacity to 
evolve quickly. Understanding basic processes of evolutionary 
change may be a necessary primary step in designing new 
intervention strategies. One of the key characteristics of RNA 
viruses, especially from an evolutionary perspective, is their 
capacity for mutation. Knowing mutation rates and the 
molecular spectrum of spontaneous mutations is important to 
understanding how the genetic composition of viral 
populations evolves. Previous studies have shown that the rate 
of spontaneous mutations for RNA viruses widely varies 
between 0.01 and 2 mutations per genome and generation, with 
plant RNA viruses always occupying the lower side of this 
range. Here we analyse the spontaneous mutational spectrum 
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and the mutation rate of Tobacco etch potyvirus (TEV), a model 
system of positive sense RNA viruses. Our experimental set up 
minimizes the action of purifying selection on the mutational 
spectrum, thus giving a picture of what types of mutations are 
produced by the viral replicase. We have estimated that the 
spontaneous mutation rate for this virus was in the range 10-6 - 
10-5 mutations per site and generation. Our estimates are in the 
same biological ballpark as previous values reported for plant 
RNA viruses. 
Recombination is a virus characteristic that also 
contributes significantly to the diversity and evolution of 
viruses. The recombination rate depends on two parameters: 
the frequency of genetic exchange between viral genomes 
within an infected host cell and the frequency of co-infected 
cells. Despite this importance, only one direct quantification of 
the in vivo recombination rate for an RNA virus during host 
infection has been reported: the in vivo recombination rate for 
Cauliflower mosaic virus (CaMV) (Froissart et al., 2005) was 
reported to be 4×10-5 events per nucleotide site and per 
replication cycle. In plant potyviruses, in vivo observations have 
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shown that strains of the same virus segregate spatially during 
mixed infections. This segregation shall minimize the chances 
of two genotypes to co-infect the same cells and henceforth, 
precludes template switching and recombination events during 
genomic RNA replication. To reconcile these confronting 
observations, we have evaluated the in vivo TEV recombination 
rate and multiplicity of infection (MOI). TEV recombination 
rate was estimated to 1.03×10−5 recombination events per 
nucleotide site and generation. This value is in the same order 
of magnitude than TEV mutation rate, suggesting that 
recombination should be at least as important as point 
mutation in creating variability. 
The multiplicity of cellular infection is defined as the 
number of viral genome infecting effectively a cell. Two recent 
studies have reported in vivo MOI estimates for Tobacco mosaic 
virus (TMV) and CaMV, using sophisticated approaches to 
measure the distribution of two virus genotypes over host cells. 
Here, we present a detailed analysis of spatial and temporal 
dynamics of the cellular MOI during colonization of a host 
plant by TEV. We observe a low frequency of virus-infected 
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cells (mean ± SD: 0.100 ± 0.073), and cells infected by both virus 
variants (mean ± SD: 0.012 ± 0.023). A new, model-selection-
based method was used to determine the MOI, and the 
predicted MOIs values were low, ranging from 1.0 (leaf three, 3 
days post inoculation (dpi)) to 1.6 (leaf four, 7 dpi).  
Finally, high genetic diversity in viral population gives 
rise to a cloud of variants; linked through mutation, interacting 
and contributing collectively; also called quasi-species. Viral 
populations can rapidly adapt to dynamic environments, 
remaining remarkably unstable under certain conditions as 
observed during evolution of TEV in case of genetic and 
functional redundancy. Large deletions and multiple defective 
particles were observed after various passages of long time 
TEV infection in transgenics plants expressing the viral 
replicase NIb. This result demonstrates the great genome 
plasticity of RNA virus and their capacity to eliminate any 
useless genetic load. 
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PROLOGUE 
 
During the last decades, we have witnessed the 
emergence of many new diseases with potentially devastating 
effects for people’s health, livelistocks, agriculture, and 
environments. A large majority of these new diseases are 
caused by viruses, and in particular the RNA viruses, such as 
HIV-1/AIDS, SARS-coronavirus or new and rare reassortants 
of Influenza A virus (IAV). Despite advances in medicine and 
research, the amount of human suffering caused is 
unacceptable. For example, there are two million new HIV-1 
cases per year and almost 30 million accumulated deaths since 
HIV-1 first discovered (UNAIDS, 2010). Moreover, the 
economic cost associated with viral infections is also enormous. 
Each year, the total cost of IAV infections in the USA alone is 
estimated to be $50 billion (World Health Organization, 2003). 
Emerging plant viruses are also common and known to induce 
enormous economic losses in crops (Navas-Castillo et al., 2011; 
Roossinck, 2008) estimated to $60 billion (Cann, 2005). Most of 
the studies on emerging viruses undertaken to date have 
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focused on the ecological processes that determine pathogen 
transmission dynamics (Antia et al., 2003; Woolhouse, 2002). 
Nevertheless, it is still unclear what evolutionary characteristics 
of virus determine their capacity to invade new host species 
(Parrish et al., 2008), and to escape from vaccines and antiviral 
strategies (Farci et al., 2000). As E.C Holmes has said “To 
understand how RNA viruses are able to jump species boundaries and 
spread in new hosts it is essential to determine the basic processes of 
evolutionary change in these infectious agents”. RNA viruses 
evolution is largely determined by high rates of mutation and 
recombination, and taking into account their extremely small 
genomes and their enormous population size, evolution of 
these infectious agents looks imprevisible but not inexplicable. 
Indeed, we can take advantage of their small and 
rapidly evolving genome to make viruses the ideal system to 
work on evolutionary dynamics. Others characteristics as the 
amount of sequenced genomes data in GenBank, their 
enormous population size, the knowledge of life cycle virus, 
viral protein structure and function make them a powerful tool 
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to study evolutionary process and define fundamental life-
history traits. 
	    
	   28	  
	    
	   29	  
INTRODUCTION 
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1. Mutation rate 	  
1a. Sources of genetic variations 
Mutation is the most important evolutionary source of 
genetic changes on which natural selection and random drift 
operate. A mutation event is defined by a genome modification 
such as the substitution, deletion or addition of a nucleotide, 
and it is generally caused by replication errors. Since the first 
study on bacteriophages in 1940s, replicase fidelity has been 
well studied. RNA-dependent RNA polymerases (RdRps) are 
known to be the most error-prone, followed by 
retrotranscriptases, RNA-dependent DNA polymerases and 
finally DNA polymerases (Flint et al., 2004). Viral replicases 
differ biochemically between viruses, which suggests a 
plausible source of variation in mutation frequency. 
The lack of a proofreading function in RdRps, for 
example, is the most important difference between RNA and 
DNA polymerases. Misincorporations during the amplification 
of RNA virus genomes by their RdRps cannot be corrected 
during replication, and result in an increase of the mutation 
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rate by one or two orders of magnitude, as compared to DNA 
replicases (García-Díaz and Bebeneck, 2007). 
A second source of variation is viral sequence 
composition. Chemical base modifications such as oxidation, 
methylation or deamination can also affect the mutation rate 
(Caride et al., 2002; Drake, 1993; Mangeat et al., 2003). Base-
repeated of AU	   rich regions can cause polymerase slippage 
during replication, causing a decrease of replicase fidelity and 
processivity (Nagy et al., 1999). Finally, it was demonstrated 
that RNA secondary structures such as hairpins have a strong 
impact on variation in mutation rates, causing replicase pauses, 
which could lead to deletions and imprecise homologous 
recombination (Nagy and Bujarski, 1996; Pathak and Temin, 
1992). 
A third source of variation is the mode of viral 
replication of (+) and (-) strands, which can be exemplified by 
two extreme models: the linear model called “stamping 
machine” and the geometrical model (Loverdo et al., 2012; 
Sardanyés et al., 2009; Thébaud et al., 2010). These models 
(Figure 1-1) impact differently the pattern of intra-cell mutation 
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accumulation in the riboviral genome. For the geometric model, 
RNA strands of each polarity are copied into their respective 
complementary strands with the same efficiency. In this case, 
mutations should accumulate geometrically: a mutated 
template would propagate the given error to all of its replicate 
copies, resulting in a relatively high mutation frequency (Luria 
and Delbruck, 1943). On the other hand, for the stamping 
machine model the RNA initially infecting the cell is the 
template for the asymmetric synthesis of genomic RNAs. Thus, 
given the same intrinsic rate of polymerase error, stamping-
machine replication would result in lower mutation frequency 
than geometric genome replication (Drake, 1993; Drake and 
Holland 1999). Two studies on riboviral replication strategy 
suggest that these viruses replicate their genome mostly using 
the “stamping machine” model (Chao et al., 2002; Martínez et 
al., 2011). 
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Figure 1-1. Scenarios describing the mode of the viral RNA 
amplification process. 
 
1b. Mutation rate estimations 
The rate of spontaneous mutation is a key parameter to 
understand the genetic structure of populations over time. 
Generally, RNA viruses have an extremely high mutation rate, 
higher than what is generally observed for DNA viruses 
(Figure 1-2-A) (Drake et al., 1998). Nevertheless, a broad range 
of mutation rates has been observed (Figure 1-2-B), from 1.1×10-
3 mutations per nucleotide and per cell infection cycle (m/n/c) 
in the positive single-stranded (ss) RNA phage Qβ (Batschelet 
et al., 1976) to 1.7×10-6 m/n/c in the negative ssRNA Influenza B 
virus (Nobusawa and Sato, 2006). To achieve polymerase 
activity retroviruses use the RT, which could be less error prone 
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than the RdRp of RNA viruses (Drake et al., 1998). It is therefore 
somewhat surprising that retroviruses appear to have the same 
mutation rate as RNA viruses (Sanjuán et al., 2010). 
Furthermore, a significant correlation was observed between 
virus genome size and mutation rate of (+)ssRNA, (-)ssRNA 
and dsRNA viruses: the smaller the viral genome the higher the 
mutation rate (Sanjuán et al., 2010). It was suggested that RNA 
viruses evolve to genome sizes just below the upper limit 
supported by their mutation rate (Eigen, 1971; Swetina and 
Schuster, 1982), which implies that polymerase complexity, 
genome size and mutation rate are inextricably linked. For 
example, RNA viruses with larger genome sizes will 
accumulate more deleterious mutations than those with smaller 
genomes, ceteris paribus. The only way to increase size genome 
and genetic complexity would therefore be to increase 
replication fidelity. To replicate with greater fidelity, however, 
requires a polymerase with proofreading activity. This leads to 
a conundrum called Eigen’s paradox: to obtain proofreading 
activity, an RNA virus must already have a higher genome size. 
(Smith and Szathmáry, 1995). 
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Figure 1-2. (A) Relationship between RNA/DNA virus 
genome size and mutation rates. (B) Relationship between 
RNA virus genome size and mutation rates. Data were taken 
from http://www.uv.es/rsanjuan/virmut.htm. 
 
Finally, a number of misconceptions and biases 
concerning mutation rate estimation have been reported. First, 
a clear distinction must be made between the mutation 
frequency and rate (Drake, 1993; Sanjuán et al., 2010). Mutation 
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frequency is the actual number of mutations observed during 
the experiment, whereas mutation rate is the estimated rate at 
which mutations occured during some time interval. This time 
interval can be one viral replication event, one round of 
replication, an infectious cycle, etc. The necessity to include 
time in the estimation of mutation rates leads to a further 
complication: the different units of time used (per replication, 
per generation or per infectious cycle). Sanjuan et al. (2010), 
reviewed various studies to facilitate comparative analyses 
using two time intervals: per strand copying event or per 
infected cell. These common time intervals finally allow for 
meaningful comparisons of the mutation rates of different RNA 
viruses. To correct the different mutation rates, the authors also 
proposed different strategies in function of the sampling 
method, taking into account two important biases: (i) errors 
induced by PCR amplification and (ii) purifying selection 
against or positive selection for mutants (Sanjuán et al., 2010). 
For example, bias induced by selection could be eliminated 
using a neutral target (Malpica et al., 2002; Tromas and Elena, 
2010). 
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1c. High mutation rate selection 
It has been argued that high mutation rates were 
selected to generate diversity in virus populations, and hereby 
allow them to confront the host immune system, rapid 
environment change (Giraud et al., 2001) or vaccines and 
antiviral drugs (Gerrish and García-Lerma, 2003). Although, 
low fidelity polymerases generate more variation, the majority 
comprises deleterious mutations that lead to a population 
generally less fit for a stable set of conditions. However, these 
variations may endow a population with the capacity to 
dominate if a sudden change in environment occurs. 
Conversely, a homogeneous viral population generated by 
conservative replication might be at a disadvantage in a 
variable host environment. Recent work with poliovirus (PV) 
by two groups provides experimental support for this idea. 
Thanks to a specific mutation, the authors observed a 
significative increase of the poliovirus polymerase fidelity. Both 
this high-fidelity virus as well as the WT poliovirus were able 
to replicate with a lower fitness, a lower virulence and with a 
restriction of tissue tropism (Pfeiffer and Kirkegaard, 2005; 
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Vignuzzi et al., 2006). Nevertheless, there is still no 
experimental proof for the proposed selective advantage of 
high genomic variation: no evidence has been found to support 
a positive correlation between mutation and adaptation rates, 
as one would expect according to this hypothesis (Clune et al., 
2008). 
An alternative explanation to the adaptive value of the 
high mutation rates is the existence of a trade-off between 
replication accuracy and efficiency, such that high mutation 
rates are only a consequence of selection for rapid replication. 
Two studies support this hypothesis, identifying the fitness 
costs of higher fidelity, such as a lower replication rate (Furió et 
al., 2005; 2007). Furthermore, recent works have demonstrated 
that more robust viral populations can be superior competitors, 
despite having lower replication rates (Codoñer et al., 2006; 
Sanjuán et al, 2007). This phenomenon (Figure 1-3) is called the 
“survival of the flattest” and occurs when robust genotypes 
produce equally fit phenotypes (i.e., mutations are neutral) 
while non-robust genotypes suffer from mutational fitness 
effects. In this case, RNA virus evolve as quasi-especies (Eigen, 
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1996); i.e., a cloud of closely related genomes through 
mutations. One prediction of quasispecies theory is that at high 
mutation rates a slow-replicating quasi-species can outcompete 
a faster-replicating one if the first is more robust to deleterious 
mutational effects (Van Nimwegen et al., 1999; Wilke, 2001). 
 
 
Figure 1-3. Hypothetical populations located at regions of 
sequence space that differ in their neutrality. In red, a 
population with high replication rate but low mutational 
robustness. In blue, a “flat” population with lower replication 
rate but a higher robustness. Left panel: Dots depict individuals 
located on each peak at low and high mutation rates. Right 
panel: Qualitatively expected distribution of individual fitness 
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values for the two populations. Individuals located at the top of 
the high narrow peak benefit from the highest fitness, although 
the other population shows lower variance in fitness due to its 
higher mutational robustness. At low mutation rates, the fitter 
population will always outcompete the flatter population, but 
the situation can be reversed at high mutation rates (from 
Sanjuán et al., 2007). 
 
It has indeed been demonstrated that selection could 
induce mutation rate variation under different fitness 
landscape profiles (smooth or rugged), and should be reduced 
on rugged landscapes but not on smooth ones to avoid harmful 
mutation production. Then it seems that under certain 
conditions (i.e., the geometry of fitness landscape), mutation 
rates could vary, moving away from optimal rates so as to 
obtain short-term benefits while limiting adaptation on the long 
run (Clune et al., 2008). 
 
1d. High mutation rate consequences 
The majority of mutations are deleterious as 
demonstrated in previous studies on Vesicular stomatitis virus 
(VSV), where up to 40% of random mutations were lethal and 
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29.2% were deleterious (Sanjuán et al., 2004b), and on TEV, 
where 40.9% were lethal and 36.4% were deleterious (Carrasco 
et al., 2007). The principal consequence of high mutation rate is 
the accumulation of deleterious mutations in viral population 
and the associated fitness loss in the absence of purifying 
selection (Chao, 1990; De la Iglesia and Elena, 2007; Duarte et 
al., 1992; Escarmís et al., 1996; Yuste et al., 1999). This 
phenomenon has also been confirmed using mutagens such as 
ribavirin or 5-fluorouracil. Different authors have shown that 
artificially increased mutation rates induce higher mutational 
loads and major decreases of fitness, probably to the point that 
the viral population eventually goes extinct (Crotty et al., 2000; 
Loeb et al., 1999; Sierra et al., 2000). How can RNA viruses 
therefore maintain their high mutation rates? 
Mutational robustness, i.e. phenotypic constancy in the 
face of mutational changes to the genome (Montville et al., 
2005), could be a characteristic approach for RNA viruses to 
deal with the accumulation of deleterious mutations. As viral 
RNA genomes do not contain any redundancy mechanisms, 
such as gene duplications or overlapping gene functions, the 
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impact of each mutation will be strong. In large populations, if 
the majority of mutations are deleterious, as expected for an 
anti-redundancy strategy, a new kind of robustness might be 
arising through population-level strategies that facilitate the 
preservation of the non-mutated genotype (Krakauer and 
Plotkin, 2002). 
Previous studies confirmed the existence of genetic 
robustness in RNA viruses (Bonhoeffer et al., 2004; Burch and 
Chao, 2004; Lalić and Elena, 2012; Sanjuán et al., 2004b) and 
suggested that antagonistic epistasis (the combined effect of 
mutations being weaker than expected under a multiplicative 
model) is a characteristic trait of RNA viruses to minimize 
deleterious mutational effects. Antagonistic or positive epistasis 
can be explained by the multiple-hit-effect in a compact 
genome with widespread RNA secondary structures, essential 
multifunction proteins and overlapping genes without 
redundancy systems, thus meaning that a single mutation in 
one viral gene could cause a major negative impact on fitness. 
After this initial loss, further mutations that occur in this viral 
gene may have a comparatively lesser impact. Interestingly, 
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antagonistic epistasis and robustness appear to be inversely 
correlated such that antagonistic epistasis is correlated with 
weak robustness (Elena et al., 2006; Sanjuán and Elena, 2006). 
Finally, complementation of defective or less-fit genotypes by 
viruses with higher fitness during co-infection can be viewed as 
a form of robustness (Froissart et al., 2004). Thus, defective or 
less-fit genotypes are maintained in the viral population, 
leading to selection acting with a lower efficiency to purge 
harmful mutations, and ultimately to a higher mutational load 
in the viral population. Indeed, complementation may be 
advantageous in the short term, because the cost of deleterious 
mutations could be partially or fully masked. Conversely, in the 
long term, complementation could slow the rate at which 
deleterious alleles are eliminated from the virus population. To 
counterbalance this, two different mechanisms were suggested: 
(i) genetic bottlenecks during cell-to-cell movement that allow a 
rapid selection to efficiently separate fit from defective 
genomes (Miyashita and Kishino, 2010) and (ii) recombination 
events that occur in co-infected cells, which could help viral 
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population to recover the non-mutated genotype (Carpenter 
and Simons, 1996; Lai, 1992; Otto and Lenormand, 2002). 
 
2. Recombination 	  
2a. Definition and mechanisms 
Until its first observation in PV by Hirst (1962) and 
Ledinko (1963), the role of recombination in RNA viruses was 
underestimated and it was thought to be restricted to DNA 
molecules. In 1982, recombination was finally demonstrated 
experimentally for the first time by biochemical and genetic 
analyses of Foot-and-mouth disease virus (King et al., 1982). RNA-
RNA recombination is now well accepted as a common 
phenomenon in RNA viruses and has been observed in an 
increasing number of animal (Bergmann et al., 1992; Lai et al., 
1985; Zhuang et al., 2006), plant (Beck and Dawson, 1990; 
Bujarski and Kaesberg, 1986; Gal-On et al., 1998) and bacterial 
riboviruses (Munishkin et al., 1988; Onodera et al., 1993). 
Mechanistically, RNA-RNA recombination in viruses can be 
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defined as an exchange of genetic material between at least two 
different viral genomes subjected to a replicase-driven-
template-switching action. To recombine, at least three kinds of 
RNAs are necessary: the donor RNA strand, the nascent strand 
synthesized from the donor RNA template, and the acceptor 
strand. Generally, template switching occurs when the RdRp 
stops nascent RNA synthesis due to the RNA donor sequence 
or RNA secondary structures (Nagy and Bujarski, 1995; 1996). 
Then the RdRp must be able to bind the RNA acceptor and 
reinitiate RNA synthesis using the 3’ end of the nascent RNA as 
a primer. Three classes of recombination (Figure 2-1) have been 
proposed to define precisely the mechanism of template 
switching (Nagy and Simon, 1997): the first class is base-pairing 
dependent, requires short (15 – 60 nucleotides) similar 
sequence (Nagy and Bujarski, 1995) and a perfect alignment 
between the donor and acceptor RNA. In the absence of a strict 
alignment of the parental RNAs, recombination crossovers may 
occur and lead to sequence insertions or deletions. The second 
recombination class does not require similarity between 
sequences, but other features such as RdRp binding sequences, 
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RNA secondary structure, heteroduplex formation between 
parental RNAs or cis-acting replication elements. Indeed, a 
previous study showed that for this kind of mechanism, RNA 
specific structures such as a heteroduplex between parental 
RNAs could drive the template switching (Nagy and Bujarski, 
1993; Nagy et al., 1995). The last recombination class combines 
the characteristics of the two first classes. Sequence similarity 
between parental RNAs influences sites and frequency of 
recombination but RNA secondary structure (e.g., a hairpin) in 
the acceptor RNA region is also necessary to recruit the RdRp 
(Nagy et al., 1998). 
 
Figure 2-1. Recombination mechanisms (Inspired by Nagy and 
Simon, 1997). 
1-Base-pairing dependent  
2-Secondary structure or cis-
acting replication element  
dependent  
3-Combination of 1 and 2 
Acceptor RNA 
Donor RNA 
Nascient RNA 
Acceptor RNA 
Donor RNA 
Nascient RNA 
Acceptor RNA 
Donor RNA 
Nascient RNA 
RdRp pausing/termination or RNA breakage 
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2b. Recombination rates estimation 
Due to the difficulties with detecting recombination 
events in some RNA viruses and the lack of standardized 
estimation methods, different strategies have been taken to 
estimate RNA recombination rates. These strategies include 
phylogenetic methods	   (Chare and Holmes, 2005; Codoñer and 
Elena, 2008; Martín et al., 2009; Ohshima et al., 2007; Revers et 
al., 1996), cell culture (Kirkegaard and Baltimore, 1986; Levy et 
al., 2004; Reiter et al., 2011),	   or	   in vivo (Bruyere et al., 2000; 
Froissart et al., 2005; Urbanowicz et al., 2005). A direct 
consequence of the use of various approaches to measure 
recombination rates is that highly variable frequencies of 
recombination have been observed in RNA viruses, although 
these variable frequencies probably also reflect the variability 
within RNA viruses to some extent. For example, 
recombination appears to occur frequently in some retroviruses 
such as the Human immunodeficiency virus type 1 (HIV-1), which 
has an estimated recombination rate of between 3×10−4 and 
1×10−5 events per site per generation (Batorsky et al., 2011; Jetzt 
et al., 2000), Spleen necrosis virus (SNV), with 4×10−5 events per 
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site per generation (Anderson et al., 1998) and Moloney’s Murine 
Leukemia virus (MMuLV) with an estimation rate estimated 
between 4.6×10−4 and 4.7×10−5 events per site per generation 
(Anderson et al., 1998; Zhuang et al., 2006). 
For plant RNA viruses, evidences of recombination 
were reported in different viral families such as the 
Bromoviridae (Bruyere et al., 2000; Urbanowicz et al., 2005) and 
Potyviridae (Gibbs and Ohshima, 2010). In 2005, the first 
estimate of the in vivo recombination rate for a plant 
pararetrovirus was reported, for CaMV (Froissart et al., 2005). It 
was found that recombination was frequent and estimated its 
rate to be 4×10-5 events per nucleotide site and per replication 
cycle. 
However, recombination appears to be far less frequent 
in other families of (+)ssRNA viruses, including the Flaviviridae, 
which is the case of Hepatitis C virus (HCV), with only 4×10−8 
events per site per generation (Reiter et al., 2011). Nevertheless, 
as is the case with HCV or other members of viral families like 
Flaviviridae (Carney et al. 2012); technical limitations appear to 
be the reason for such low recombination rate estimates 
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(González-Candelas et al., 2011). Indeed, yet today, 
recombination has not been detected in a number of (+)ssRNA 
viruses, including members of the families Barnaviridae, 
Leviviridae, and Narnaviridae. This lack of detection may reflect 
the limited amount of data available. Surprisingly, current data 
indicate that recombination is even less frequent in (−)ssRNA 
viruses (Chare et al., 2003). For example, in Rhabdoviridae family, 
viral RNA is condensed by the nucleoprotein into a helical 
nucleocapsid also called ribonucleoprotein complex (RNP). 
This complex serves as a template for replication should not 
allow template switching and apparently never disassembles 
(Simon-Loriere and Holmes, 2011). Another example revealed 
only sporadic evidences for homologous recombination, after a 
large analysis of Influenza A virus genomic sequences from 
virus isolates (Boni et al., 2010). 
 
2c. Evolutionary advantages and constraints of RNA 
recombination 
It is still not clear why high RNA virus recombination 
rates have been selected, but an important number of studies 
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have described roles for recombination that may explain its 
evolutionary success. On the one hand, recombination may be a 
means to create novel genotypes, mitigating the effects of clonal 
interference and accelerating the rate at which multiple 
beneficial mutations can accumulate within the same genome. 
In this sense, recombination may play an important role in the 
development of drug resistance (Nora et al., 2007; Pamilo and 
Li, 1987; Yusa et al., 1997) and would act as an accelerator of 
variability. On the other hand, one could imagine that 
recombination would also accelerate the combination of 
deleterious mutation and hereby help to increase the 
mutational load. Indeed, it was found that sex can be 
advantageous for counteracting the accumulation of deleterious 
mutations when those mutations are negatively epistatic or 
more harmful together than would be expected from their 
separate effects (Eshel and Feldman, 1970). Nevertheless, 
previous studies suggest that even if epistatic interactions are a 
common phenomenon, they tend to be positive (Bonhoeffer et 
al., 2004; Lalić and Elena, 2012; Sanjuán et al., 2004a; Shapiro et 
al., 2006). 
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Furthermore, recombination has been shown to increase 
the efficiency with which deleterious mutations are purged 
(Chao et al., 1992; Simon-Loriere and Holmes, 2011). Indeed, 
high mutation rates combined with small population sizes 
during viral transmission result in Muller’s ratchet dominating 
the evolutionary dynamics	  (Chao, 1990; De la Iglesia and Elena, 
2007; Muller, 1964). In its simplest form, this theory states that 
accumulation of deleterious mutations in small asexual 
populations leads to a progressive decrease in fitness, and that 
genetic random drift accelerates the loss of mutation-free 
individuals. Then, recombination would help to halt Muller’s 
ratchet in viral population. 
In addition to the evidence favouring a role for genetic 
exchange in fixing beneficial alleles or eliminating deleterious 
ones, recombination could provide viruses with genetic new 
variation by borrowing host genetic material. One surprising 
example of this is Bovine viral diarrhoea virus (BVDV), a 
pestivirus that recombines with host cellular protein-coding 
RNAs. Cytopathogenic pestivirus strains originated from 
noncytopathogenic viruses by nonhomologous RNA 
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recombination and caused host death (Meyers et al., 1989a). 
Therefore, by allowing the generation of new combinations of 
genes, recombination permits the population to explore regions 
of the genotypic space that were not represented in the 
previous generations and thus, under selection pressure, 
generate new viral genome variants with a different genomic 
organization (Crow, 1992). 
However, constraints also exist, as there are costs 
associated with sex in RNA viruses. These costs include an 
increasing degree of intra-host competition under those 
conditions that foster high recombination rates (Turner and 
Chao, 1998). Indeed, because recombination between standing 
genetic variation can occur only during co-infection, the 
different genotypes must be in direct competition within the 
host. Then, social behaviours trait as cheating could be selected 
for under certain conditions (Turner and Chao, 2003).  
Finally it has been suggested that recombination was 
selected as a repair mechanism driven by genetic damage, 
instead of a mechanism for sex:	   various experimental studies 
showed that weak or even non- replicative mutant strains could 
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recombine to form viable ones. White and Morris (1994) 
described the formation of functional genomes thanks to 
recombination between nonreplicating RNAs and DI RNAs of 
tombusviruses. Furthermore, examples of infectious 
recombinants generated by different combinations of 
mutationally altered Sindbis virus RNAs were also described 
(Raju et al., 1995; Weiss and Schlesinger, 1991). Plant viruses 
have also been observed to repair their genomes by 
recombining with host transgene transcripts (Borja et al., 1999; 
Gal-On et al., 1998; Greene and Allison, 1994; Rubio et al., 1999). 
Similarly, in one experiment with a deletion mutant of Mouse 
hepatitis virus (MHV) transfected with a synthetic RNA that 
contained the deleted region (Koetzner et al., 1992) 
recombination successfully repaired defective genes. It was 
eventually proposed that recombination could only be a by-
product of the processivity of RNA polymerases (Simon-
Loriere and Holmes, 2011). This theory suggests that genome 
organization and gene expression control are negatively 
correlated with recombination rate, based on the fact that 
(−)ssRNA viruses have more options than (+)ssRNA viruses for 
	   54	  
the control of gene expression and that recombination rates for 
(−)ssRNA are very low (Chare et al., 2003). 
 
3. Estimation of the multiplicity of infection (MOI) 
during RNA virus dynamic infection in a multicellular 
host 	  
3a. Definition 
The cellular multiplicity of infection (MOI), that is, the 
mean number of virions effectively infecting each cell, is a key 
parameter for understanding the dynamics and evolution of 
virus populations. This number is highly relevant for virus 
evolution because: (i) MOI is a determinant of the amount of 
genetic drift at the cellular level and the distribution of different 
viral genotypes over cells, (ii) complementation, recombination 
or reassortment between different genotypes can only occur in 
mixed-genotype infected cells (Figure 3-1), whilst mixed-
genotype infections can only occur if the MOI > 1, (iii) MOI will 
be a determinant of the respective importance of different 
levels of selection in viral evolution, and (iv) for many viruses, 
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defective interfering particles can be generated and maintained 
for substantial periods of time if MOI is high.  Competition 
between virus genotypes occurs at the between-host, within-
host, within-tissue and within-cell levels, and the relative 
importance of different levels of selection is modulated by MOI.  
For example, low MOI levels (MOI ≈ 1) relax selection at the 
within-cell level and increase selection at higher levels 
(Froissart et al., 2004; Miyashita and Kishino, 2010; Taylor et al., 
2002; Turner and Chao, 1999, 2003; Zwart et al., 2008).  Cellular 
MOI is therefore not only relevant to mechanisms at the cellular 
level, but is of great relevance to understanding viral evolution. 
 
3b. MOI estimation in a multicellular host 
At first glance the concept of MOI is straightforward: it 
is the mean number of virions successfully infecting a 
population of cells.  There are, however, two possible ways to 
define MOI: (i) the average number of infecting virions over the 
total number of cells, or (ii) the average number of infecting 
virions in infected cells. Both definitions are valid and are likely 
to be used in different contexts. The first definition is 
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particularly useful for describing manipulable units in an 
experiment (e.g., virion dose and the number of cells for 
infections of cultured cells).  The second definition, however, 
gives a more readily interpretable value for understanding the 
population genetics and evolution of a virus population. In this 
case we are only interested in infected cells because no viral 
replication or interactions between genotypes occur in 
uninfected cells. However, in both cases there are problems 
when applying these concepts to a complex multi-cellular host. 
In particular, two important assumptions are being made: (i) 
the population of cells is homogenous, with each cell being 
equally susceptible to viral infection, and (ii) there is free 
mixing of virions and cells, such that each cell is equally 
accessible to virions. Moreover, if two virus variants are used to 
estimate MOI, then there must also be free mixing of the two 
virus variants. Although these assumptions may be largely met 
for a monolayer of cultured cells, they will probably not be met 
for a multi-cellular organism, with its complex spatial 
organization of differentiated cells with varying susceptibilities 
(Morra and Petty, 2000; Silva et al., 2002). A key question is 
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therefore to what extent the assumptions of current MOI 
models are met, and whether this has important implications 
for making meaningful in vivo MOI estimates. 
 
Figure 3-1. Distribution of two engineered TEV genotypes 
(TEV-GFP and TEV-mCherry). Confocal imaging of mixed 
infections in systemically infected N. tabacum cv. Xanthi 
tissues.  
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3c. MOI previous estimations 
Despite of its importance, only few estimates of MOI in 
the natural hosts of viruses have been undertaken: values of 
two to three were reported for an RNA bacteriophage 
(Olkkonen and Bamford, 1989; Turner et al., 1999), and values 
of four to five were reported for the final round of Autographa 
californica multiple nucleopolyhedrovirus (AcMNPV) replication in 
its insect host (Bull et al., 2001). Recently, three studies reported, 
for the first time, estimates of the in vivo MOI during host 
colonization for plant viruses (González-Jara et al., 2009; 
Gutiérrez et al., 2010; Miyashita and Kishino, 2010). For Tobacco 
mosaic virus (TMV), MOI was measured by infecting a host with 
virus variants marked with different markers, determining 
which cells were infected with one or both variants, and then 
using a simple mathematical model to estimate MOI (González-
Jara et al., 2009). This approach was used to show that the MOI 
during TMV infection of Nicotiana benthamiana ranges from four 
during initial infection to two during early systemic infection. 
Similar experiments were performed for CaMV infection of 
Brassica rapa, although here MOI rose from two to 13 as the 
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virus expanded, and dropped to two again as the infection 
progressed even further. Finally, a similar experimental 
approach was also used to estimate MOI during primary 
infection of Soil-borne wheat mosaic virus (SbWMV), although a 
model considering the separation of genotypes at the cellular 
level was used to estimate MOI. This analysis rendered an 
estimated MOI of six and five for the first and second rounds of 
cellular replication, respectively (Miyashita and Kishino, 2010). 
 
4. Organization of RNA viruses 	  
4a. Evolution of genome size 
Most RNA virus genomes have two evolutionary 
characteristics: a high variability and an extremely small size. 
Nevertheless, a large range of genome sizes has been found for 
RNA viruses, with a large majority having a genome size of 
between 5000 and 15000 nucleotides. Two notable exceptions 
are members of Narnaviridae (< 4000 nucleotides) that have the 
smallest RNA genomes, and members of Coronaviridae (> 30000 
nucleotides) that have the largest ones. So what could explain 
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this range of genome sizes in RNA viruses? In one hand, the 
features of small genomes lead to apparently lower enzymatic 
complexity, lower fidelity replication enzymes and so on higher 
variability (Smith and Szathmáry, 1995). Thus, a clear 
advantage of a smaller genome would be to replicate quickly; 
taking advantage of a high degree of optimization. In the other 
hand, a larger genome size allows genetic complexities such as 
greater replication fidelity, as described in Coronaviruses 
(Denison et al., 2011), and/or allows them to modulate host 
immune response (Shackelton and Holmes, 2004). Therefore, it 
appears that each genome size has its own advantages, and 
interestingly various RNA viruses with different genome sizes 
could infect and evolve into the same host (Holmes, 2009). 
 
4b. Process leading to an increase of genome size 
If RNA viruses are really limited in their genome size 
due to the biochemical properties of their RdRp, then we 
should not observe increases in the genome size of RNA 
viruses. Indeed, few examples of the integration of host genetic 
material into RNA genomes have been observed, and most of 
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the observed cases concern BVDV, where inserts of host 
ubiquitin genes were found (Meyers et al., 1989b). Those 
insertions had a direct impact on the cytopathogenicity, leading 
to positive selection for these BVDV variants. In a similar way, 
only few examples of viral gene duplications have been 
observed in RNA viruses, such as short duplications in the 
UTRs flanking conding sequences (Gritsun and Gould, 2006) or 
gene duplication involving intra-genic regions that result 
mainly in defective viruses (Nagai et al., 2003). Why those 
different examples are an exception? When a host gene is 
inserted into a viral genome, the size of the RNA genome 
increases, that could implicates an increase of replication time, 
a loss of replication accuracy and so on a reduced viral fitness 
(Holmes, 2009). For example, Dolja et al. (1993) described large 
deletions in a foreign gene, GUS, inserted into TEV genome. 
 
4c. Non-retroviral integrated RNA viruses 
On the other hand, there have been recent reports of the 
integration of large amounts of non-retroviral (without DNA 
stage) RNA virus genes into eukaryotic genomes. These 
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integred sequences have been named as non-retroviral 
integrated RNA viruses (NIRV) and have been found in 
mammals (Belyi et al., 2010; Geuking et al., 2009; Horie et al., 
2010; Katzourakis and Gifford, 2010) plants (Chiba et al., 2011) 
and fungi (Taylor and Bruenn, 2009) (Table 4-1). In this last 
category, NIRVs are widespread and become functional genes 
(Koonin, 2010). Interestingly, it seems that those insertions 
could confer a resistance against the original virus (Bertsch et 
al., 2009; Flegel, 2009). Therefore, a particularly interesting 
situation appears when the same virus that gave rise to the 
NIRV infects a host carrying it. How would a virus population 
evolve if faced with a situation in which functional 
redundancy, provided by the NIRV, has arisen? 
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Host Virus Gene(s) Transcription 
Fungi    
Candida 
parapsilosis 
Totivirus 
(dsRNA) related 
to Saccharomyces 
cerevisiae L-A 
(L1) virus 
Capsid 
protein (CP) 
Not tested 
Debaryomyces 
hansenii 
Totivirus 
(dsRNA) related 
to S. cerevisiae L-
A 
(L1) virus; M2 
killer virus 
(unclassified 
dsRNA virus) 
CP, RdRp; 
apparently 
complete viral 
genome with 
overlapping 
CP and RdRp 
genes as in L1 
virus; an extra 
copy of the 
CP gene; 4 
copies of K2 
toxin gene 
RdRp but not 
Cp transcripts 
detected by 
reverse 
transcriptase 
polymerase 
chain reaction 
(RT-PCR) 
Penicillium 
marneffei 
Totivirus 
(dsRNA) related 
to S. cerevisiae L-
A 
(L1) virus 
CP, RdRp; 
apparently 
complete viral 
genome with 
overlapping 
CP and RdRp 
genes as in L1 
virus 
Not tested 
Pichia stipitus Totivirus 
(dsRNA) related 
to S. cerevisiae L-
A 
(L1) virus 
CP, RdRp; 
apparently 
complete viral 
genome with 
fused CP and 
RdRp genes; 3 
extra copies of 
the CP genes 
RdRp but not 
CP transcripts 
detected by 
RT-PCR; 
transcripts of 
both genes 
detected in 
EST database 
Uromyces 
appendiculatus 
Totivirus 
(dsRNA) related 
to S. cerevisiae L-
A 
(L1) virus 
CP (from EST 
database) 
CP gene 
transcript 
detected in 
EST database 
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Candida tropicalis M2 killer virus 
(unclassified 
dsRNA virus) 
K2 toxin gene Not tested 
Kluyveromyces 
lactis 
M2 killer virus 
(unclassified 
dsRNA virus) 
K2 toxin gene 
(3 copies) 
Not tested 
Vanderwaltozyma 
polyspora 
Penicillium 
stoloniferum 
virus F 
CP Not tested 
Animals    
Mouse (Mus 
musculus) 
Lymphocytic 
choriomeningitis 
virus (negative- 
strand ssRNA, 
Arenaviridae) 
Glycoprotein 
and 
nucleoprotein 
genes (small 
genomic 
segment) 
Not tested 
Mosquitoes 
(Aedes albopictus 
and Aedes 
aegypti) 
Flavivirus 
(positive- strand 
ssRNA) related 
to Cell Fusing 
Agent and 
Kamiti River 
virus 
Non-
structural 
protein genes 
(3'-terminal 
part of the 
genome) 
Expressed 
Table 4-1. Non-retroviral integrated RNA viruses in 
eukaryotic genomes (from Koonin, 2010). CP, capsid protein; 
Ds, double-stranded; ss, single-stranded; RdRp, RNA-
dependent RNA polymerase. 
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5. Viral model: Tobacco etch virus 	  
5a. History and generalities 
A new group of viruses with filamentous flexuous 
virions was discovered by Brandes and Wetter (1959), and 
named Potyvirus (from Potato virus Y) by Harrison et al. (1971). 
Nowadays, Potyvirus is the largest of six genera within the 
family Potyviridae (Adams et al., 2005b; Shukla et al., 1994) and 
responsible for the largest losses of crop plants worldwide 
(Agrios, 1997). Potyviridae genomes belong to the “Picornavirus 
supergroup” of (+)ssRNA viruses (group IV in Baltimore’s 
classification). 
Virions of this family are generally described as non-
enveloped, flexuous filaments of 11 to 15 nm in diameter, with 
monopartite genomes of length 650-900 nm, or bipartite 
genomes of 500 - 600 and 200 - 300 nm (Shukla et al., 1998). One 
of the characteristics of the Potyviridae is to induce the 
formation of three-dimensional crystalline cytoplasmic 
inclusions (CI) within infected cells. Some members of the 
Potyvirus genus can also induce the formation of crystalline 
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nuclear inclusions (NI) that consist of two proteins, NIa and 
NIb (Shukla et al., 1998). 
 
 
Figure 5-1. An aphid (Myzus persicae) feeding on a leaf (from 
Cornell plant pathology herbarium photograh collection). 
 
All members of Potyvirus are transmitted in a non-
persistent, or stylet-borne, manner by aphid insects (Figure 5-1) 
feeding on leaves and stems. Aphids acquire the virus by 
feeding on infected plants and then, simply by means of 
passively carrying virions and in the absence of replication, 
transmitting it when feeding on uninfected plants thanks to the 
ingestion and salivation process (Gray and Banerjee, 1999). 
TEV is a well-characterized member of the genus 
Potyvirus. It is mainly distributed in North and South of 
America, and transmitted by aphid insects or by mechanical 
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inoculation. Its principal hosts are Solanaceae species where TEV 
induces mottling, necrotic etching and leaf distortion (Johnson, 
1930; 
http://www.dpvweb.net/dpv/showdpv.php?dpvno=258). 
TEV has a monopartite RNA genome of approximately 
10 kilobases (kb) covalently linked to a virus encoded protein 
(VPg) at the 5’ end and tailed with a poly(A) tail at its 3’ end 
(Riechmann et al., 1992). The TEV genome contains two open 
reading frames (ORF); ORF1 is translated into a large 346 
kilodalton (KDa) polyprotein, which is autoprocessed by the 
proteases into ten mature viral proteins (Figure 5-2). ORF2 is 
embeeded within the P3 cistron of the polyprotein. ORF2 is 
translated in the +2 reading-frame, resulting in a 7 - 17 KDa 
protein (Chung et al., 2008) named P3N-PIPO, a fusion of the N-
terminus of P3 and, following a frameshift during translation, 
PIPO. Because the small genomes of plant viruses generally 
encode fewer than a dozen proteins, the function of each viral 
protein must be well defined and optimized for host 
interaction. P1 is a trypsin-like serine peptidase corresponding 
to the 5’-terminal gene of the TEV genome, which catalyzes its 
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own cleavage from the polyprotein in its C terminus (Verchot et 
al., 1991, 1992). Helper component proteinase (HC-Pro) is a 
papain-like cysteine multidomain peptidase, also containing a 
C-terminal autocleavage domain (Carrington et al., 1989). HC-
Pro is also implicated in aphid transmission, systemic 
movement and suppression of gene silencing. P3 could be 
implied in plant pathogenecity (Riechmann et al., 1995) and 
recently, data suggested that P3N-PIPO complex acts as 
movement protein and coordinates the utilization of 
plasmodesmata, essential for systemic infection (Wei et al., 
2010). Cytoplasmic inclusion (CI) is a multidomain protein that 
is involved in cell-to-cell movement and has a helicase motif, 
suggesting it has a role in TEV replication (Carrington et al., 
1998). 6K2 is a small protein responsible for anchoring the 
replication complex to the endoplasmic reticulum via a 
hydrophobic domain (Restrepo-Hartwig and Carrington, 1994). 
The N-terminal domain of nuclear inclusion protein a (NIa-
VPg) and the nuclear inclusion protein b (NIb), which is the 
RdRp, are the viral replication machinery (Schaad et al., 1997a, 
1997b). The C-terminus of NIa is also a trypsin-like serine 
	   69	  
proteinase (NIa-Pro) involved in the maturation of replication-
associated and capsid proteins (Dougherty and Semler, 1993). 
Capsid protein (CP) functions are essential in aphid 
transmission, cell-to-cell and systemic movement (López-Moya 
and Pirone, 1998) and virus assembly (Jagadish et al., 1993). 
 
 
Figure 5-2. TEV genome organization. P1, P1 protein; HC-Pro, 
helper component-protease protein; P3, third protein; VPg, 
viral protein genome–linked; NIa-Pro, major protease of small 
nuclear inclusion protein –NIa; CP, coat protein; UTR, 
untranslated region. The functions of the genes are also 
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indicated. The cleavage site of P1 serine protease is indicated in 
red, those of HC-Pro in dark grey and those of NIa-Pro in blue. 
 
5b. TEV replication 
Figure 5-3. Schematic representation of different events 
during Potyvirus infection of a plant cell (from Encyclopedia 
of Virology, 3rd edition). 
 
The mechanisms of TEV replication are still unknown. It 
is nevertheless possible to infer with a reasonable degree of 
certainty the basis for the replication process. TEV replication 
(Figure 5-3) takes place in the cytoplasm of infected cells, and is 
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specifically localized on heaps of tubules in the endoplasmic 
reticulum (Schaad et al., 1997a), probably to avoid non-viral 
RNA replication. It is useful to differentiate between two 
different types of cellular infection: (i) the infection of the first 
cell by aphid action, and (ii) the infection of neighbouring or 
distant cells by local or long-range movement. In the case of 
local movement, both viral RNA and virions are transferred 
into the next cell via plasmodesmata (Santa Cruz et al., 1998). 
Then, replication occurs directly on the viral RNA, with an 
uncoating process if necessary, by the action of a viral RdRp. 
The NIb was characterized as the TEV RdRp (Hong and Hunt, 
1996) and could form a replication complex with other viral 
protein as CI (helicase motif), NIa-VPg (replication initiator) 
and 6K2 (endoplasmic reticulum anchoring factor). Indeed 
strong protein-protein interactions were observed between NIb 
and NIa (Li et al., 1997) and NIb and VPg (Fellers et al., 1998). 
Probably host proteins join the viral replication complex and 
finally the genomic (+)ssRNA will be used as template to 
generate a complementary (-) chain through a dsRNA 
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intermediate, and proceed with the asymmetric synthesis of 
numerous genomic RNAs (Martínez et al., 2011).  
 
5c. TEV cell-to-cell and systemic movement 
Viral infection begins with the infection of a relatively 
small number of cells in the inoculated or exposed leaf (Zwart 
et al., 2011). However, many hurdles must be surpassed before 
systemic infection of the plant is established. Indeed several 
steps are required, starting with expansion from a single 
infected epidermal cell to adjacent tissue such as mesophyll, 
bundle sheath or phloem parenchyma/companion cells 
(Carrington et al., 1996) by means of relatively slow cell-to-cell 
movement (Gillespie et al., 2002). The cell-to-cell movement of 
virions or infectious RNA requires modification of the 
plasmodesma, which are brought about by three viral proteins: 
HC-Pro, CP and a complex	  CI/P3N-PIPO that coordinates the 
formation of plasmodesmata-associated structures (Dolja et al. 
1994; Maia and Bernardi, 1996; Rojas et al., 1997; Wei et al., 
2010). However, plasmodesma structure differs according to 
the plant tissue and it has been shown that Potyvirus have a low 
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propensity to infect companion cells (Ding et al., 1998). 
Infection of companion cells to sieve elements (Ding et al., 1996) 
offers access to long distance transport within the plant, 
allowing for rapid expansion to distant tissues (Leisner et al., 
1993). The infection of companion cells appears to be a key 
process in plant colonization; where HC-Pro could play a major 
role, facilitating this passage by both loading and unloading 
virus from vascular cells (Cronin et al., 1995). Only by 
establishing systemic infection can a plant virus readily have 
access to the tissue in which vectors will feed, and hereby 
ensure its transmission to new hosts. Virions loaded into 
phloem are responsible for long-distance movement in TEV. 
During mixed-genotype infection; plants infected by 
PVX/potyvirus combinations showed synergistic symptoms 
and a large numbers of coinfected cells (Dietrich and Maiss, 
2003). In contrast, spatial segregation of closely related 
genotypes was observed during virus colonization of the host 
(Dietrich and Maiss, 2003). Indeed, in general clusters of each 
genotype are formed in leaf space; limiting superinfection by 
blocking the access for a new infection. This potyvirus 
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characteristic could be a direct consequence of the modification 
of plasmodesma during cell-to-cell movement. However, yet 
today the exclusion process, also called superinfection 
exclusion, is poorly understood and the underlying mechanism 
unknown. Superinfection exclusion protects an already infected 
cell from a second infection by a related virus. Besides 
elimination of competition for host resources, superinfection 
exclusion could help to maintain the stability of viral sequences 
by, for example, limiting opportunites for recombination 
(Folimonova, 2012). 
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MATERIALS AND METHODS 
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1. The rate and spectrum of spontaneous mutations in a 
plant RNA virus 	  
1a. Virus and plants 
The pTEV7DA (GenBank DQ986288) infectious clone 
(Dolja et al., 1992) was used as source for TEV. A TEV genotype 
was produced that lacked the full replicase gene (ΔNIb) by 
inverse PCR using Pfu turbo DNA polymerase (Stratagene) and 
primers conserving the proteolytic NIa-NIb (ΔNIb-F) and NIb-
CP (ΔNIb-R) sites (Table 1-1).  The resulting clone was named 
pTEV7DA-ΔNIb. 
Two different genotypes of N. tabacum were used in these 
experiments, the wild-type cv. Xanthi and the transgenic 
Nt::NIb line derived from cv. Samsun by Li and Carrington 
(1995). These transgenic plants express TEV NIb protein in a 
stable and functional manner. Prior to starting our experiments, 
the presence of the transgene was confirmed by PCR using Taq 
polymerase (Roche) and the primers F90-95 (identical to bases 
7767 - 7786 of TEV NIb) and R86-91 (complementary to bases 
8084 - 8102 of TEV NIb) (Table 1-1). The expression of the gene 
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also was confirmed by RT-PCR. MMuLV reverse transcriptase 
(Fermentas) was used to obtain cDNA from plants RNA 
extracts using primer R92-96 (complementary to bases 8761 - 
8779 of CP gene). Then this cDNA was amplified using Taq and 
primers F90-95 and R86-91 (Table 1-1). Finally, the biological 
activity of the NIb protein encoded by the transgene was 
confirmed by inoculating batches of Nt::NIb plants with 
infectious RNAs from both viruses. All Nt::NIb plants 
inoculated with either TEV (n = 20) or TEV-ΔNIb (n = 10) 
developed a systemic infection after 6 - 7 dpi. By contrast, none 
of the wild-type plants inoculated with TEV-ΔNIb (n = 5) 
became infected, while all plants inoculated with TEV (n = 5) 
were so. Furthermore, these results confirm that no putative 
RNA secondary folding structure within the NIb coding 
sequence is necessary for completing the infectious cycle of the 
virus. 
 
1b. Experimental procedure 
Infectious plasmid pTEV7DA was linearized with BglII 
(Takara) and transcribed into 5’-capped RNAs using the SP6 
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mMESSAGE mMACHINE kit (Ambion Inc). Transcripts were 
precipitated (1.5 volumes of DEPC-treated water, 1.5 volumes 
of 7.5 M LiCl, 50 mM EDTA), collected, and resuspended in 
DEPC-treated water (Carrasco et al., 2007). RNA integrity was 
assessed by gel electrophoresis and its concentration 
spectrophotometrically determined using a Biophotometer 
(Eppendorf). Twenty four-weeks old Nt::NIb plants were 
inoculated mechanically on the third true leaf with TEV 
transcripts (4 - 7 µg) and 10% of inoculation buffer (100 mg/mL 
carborundum, 0.5 M K2HPO4, 3% polyethylene glycol 8000, pH 
= 7). In all cases, first symptoms appeared 6 - 7 dpi. 
Total RNA was extracted using RNeasy Plant Mini Kit 
(Quiagen) from symptomatic leaves of 3 Nt::NIb plants at 5, 10, 
15, 20, 25, and 60 dpi. One of the plants at 20 dpi was not 
sampled because it dried out. The full NIb gene was reverse-
transcribed MMuLV and primer R92-96 and PCR-amplified 
using the high fidelity PrimeSTAR HS DNA polymerase 
(Takara Bio Inc) and primers F73-80 (identical to bases 6377 - 
6396 of TEV NIa gene) and R92-96 (Table 1-1). By using this 
pair of primers we ensure that only NIb sequences from viral 
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genomes and not the mRNA from the transgene will be 
amplified. PCR products of 2403 pb were gel purified with 
Zymoclean (Zymo Research), cloned into the plasmid 
pUC19/SmaI (Fermentas) and used to transform Escherichia coli 
DH5α electrocompetent cells. At least 25 clones per plant were 
purified and sent out for sequencing by GenoScreen 
(www.genoscreen.fr) using BIGDYE 3.1 and a 96-capillars 
ABI3730XL sequencing system (Applied Biosystems). The 
following five internal primers were used for fully sequencing 
NIb with overlapping readouts: F1, F2, F3, F4, F5 (Table 1-1). 
Contigs were assembled using GENEIOUS version 4.7 
(www.geneious.com). The number of clones that rendered 
useful sequences was 472 (instead of the 500 submitted for 
sequencing). The number of sequenced clones per plant ranged 
between 12 and 34, with a median value of 24. 
 
1c. Mutation rate estimations 
Two different approaches have been used to estimate 
TEV mutation rate. In the first approach, we proceeded as 
follows. For a given plant the number of clones sequenced that 
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contained zero, one, two, …, k mutations was fitted to a Poisson 
distribution with parameter λ = µlT, where λ is the expected 
number of mutations per clone, T the number of generations of 
viral replication, l = 1536 the length of the amplicon, and µ the 
mutation rate per base and per generation (m/b/g). Defining 
generations in vivo for a plant virus is troublesome, given that a 
viral population colonizing a plant is not replicating 
synchronously but with overlapping generations. A good 
approximation is to define viral generations as the number of 
cycles of cell infections (Malpica et al., 2002). For this definition 
to be operative, it is necessary first to have an estimate of the 
average number of viruses produced per infected cell. By 
performing one-step accumulation curves in tobacco 
protoplasts, Martínez et al. (2011) have estimated that, on 
average, an infected cell yields 1555 genomes (quantified by 
real-time quantitative RT-PCR). To estimate the number of 
generations experienced by TEV at the time points where the 
samples were taken, we revisited previously published data on 
the kinetics of TEV accumulation (Carrasco et al., 2007). 
Reanalyzing these data, we found that the model that better 
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describes TEV accumulation within an infected plant was a 4-
parameters Gompertz growth equation (R2 = 0.975) (Campbell 
and Madden, 1990). From the parameters of the model and 
using the above estimate of virus yield per cell, it is possible to 
calculate that during the exponential growth phase, the viral 
population experienced 3.2 generations per day, but this 
number reduces as growth rate flats off and the carrying 
capacity of the system is reached. After estimating the number 
of generations corresponding to each sampling day, it is then 
possible to transform the above per clone mutation rate values 
into the biologically meaningful scale of mutations per base and 
per generation using the simple expression µ = λ/lT. Each plant 
has been treated as an independent replicate, rendering 19 
estimates of µ. 
For the second approach, we focused only on putatively 
lethal mutations, that is, mutations generating frameshifts or 
stop codons. Readers need to recall that ORF1 encoded by TEV 
genome is translated into a single polyprotein. Our method is 
based on the fact that amino acid substitutions affecting NIb 
would in turn be neutral because the trans complementation 
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provided by the host (and the best evidence of such active trans 
complementation is the ability of TEV-ΔNIb to infect Nt::NIb 
plants). However, frameshift mutations and stop codons 
affecting the NIb sequence would be lethal because they will 
produce a virus deficient not only in NIb but also in CP, the 
gene downstream from NIb, which is not complemented by the 
host. In haploid populations at the mutation-selection balance, 
the frequency of deleterious mutations, p, is given by p = µ/s, 
where s is the selection coefficient. For lethal mutations, 
however, s = 1, then µL = p and the equilibrium is reached 
instantaneously because all lethal mutations have been 
generated in the previous generation (Crow and Kimura, 1970). 
In other words, this method provides an estimate of mutation 
rate per replication event (m/b/r) rather than by generation, as 
in the first method. Following Cuevas et al. (2009), it is possible 
to calculate a mutation rate for the ith amplicon using the 
expression 
,     (1) 
where n is the total number of nonsense mutational targets 
! 
µNSTMT , j =
1
n Wii=1
K
"
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(NSMT: sites that can generate a stop codon after a single 
nucleotide substitution) in an amplicon, Wi a weighting factor 
for the two types of nonsense mutations (Wi = 3 if only one of 
the three possible mutations in a NSMT produces a stop codon 
and Wi = 1.5 if two out of three possible produce a stop codon), 
and K is the total number of observed nonsense mutations in 
the amplicon. According to the standard genetic code, there are 
18 NSMT-containing codons and 19 different NSMTs (the UGG 
codon contains two). In our experiments, we have 472 
independent estimates of µNSMT. If the frequency of insertions 
and deletions is µindel (it can be computed using the Poisson 
distribution, as described above), then µL can be estimated as 
.    (2) 
where µNSMT,j is estimated using Equation 1. 
Hereafter, we will use the notation µL when referring to 
the estimated based on the frequency of lethals (units of 
m/b/r) and reserve the notation µ for the Poisson estimate 
(units of m/b/g). 
! 
µL = µindel +
1
472 µNSMT , jj=1
472
"
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1d. Statistical analyses 
All statistical tests were performed using IBM SPSS 
version 16. All molecular evolutionary analyses were done 
using MEGA4 (Tamura et al., 2007). 
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Primers 
TEV 
genome 
position 
(5’) 
Sequence (5’ to 3’) 
ΔNIb-F 6940 TTGCGAGTACACCAATTCACTCATGAGTTGAGTCGCTTCCTT 
ΔNIb-R 8518 AGTGGCACTGTGGGTGCTGGTGTTGACGCTGGTAAGAAGAAA 
73-80-F 6377 TCATTACAAACAAGCACTTG 
90-95-F 7768 GCTGTATTGAAAGTGCGAC 
86-91-R 8084 AGGCCCAACTCTCCGAAAG 
92-96-R 8762 GCAAACTGCTCATGTGTGG 
F1 6911 GCAAACCTGAAGAGCCTTTTCAG 
F2 7265 GCATGCTCATCACAAAGCTCAAG 
F3 7591 GTGGATGATTTCAACAATCAATTTTATGAT 
F4 8531 ACCAGCGTCAACACCAGCAC 
F5 8215 GATCTGTCCCATTCCAAAATAGAAAC 
Table 1-1. List of primers used to amplify or sequence TEV 
genome. 
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2. Estimation of the in vivo recombination rate for a 
plant RNA virus 	  
2a. Generation of restriction sites as genetic markers 
We used the pTEV7DA infectious clone (Dolja et al., 1992) 
as a source for TEV. To analyze TEV recombination rate, we 
introduced five genetic neutral markers, in the form of artificial 
restriction sites, along TEV genome. New AscI, PmeI and SgfI 
restriction sites were created at positions 402, 3735 and 9463, 
respectively, whereas natural restrictions sites Eco47III and SalI 
were removed from positions 4969 and 7166, respectively 
(Figure 2-2A). All mutations necessary to create or remove 
restriction sites were introduced by PCR-directed mutagenesis 
using the Quickchange® II XL kit (Stratagene) and following the 
indications given by the manufacturer. In all cases, mutations 
rendered synonymous substitutions. Table 2-1 shows the pairs 
of primers used for mutagenesis, that were also designed 
following Stratagene’s recommendations. To minimize 
unwanted errors during the mutagenesis process, the kit 
incorporates the PfuUltraTM high fidelity DNA polymerase 
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(Stratagene). The amplification conditions were 1 min at 95ºC 
(initial denaturation), followed by 18 cycles consisting of 30 s at 
95 ºC, 45 s at 65 ºC and 18 min at 68 ºC, and a final extension 
step of 28 min at 68ºC. PCR products were digested with DpnI 
(New England Biolabs) to remove the parental methylated 
strands and transformed into electrocompetent E. coli DH5α. At 
least 15 clones were sequenced to confirm the successful 
incorporation of desired mutations. 
 
2b. Neutrality of restriction markers 
Sequence-validated plasmids containing the 
corresponding restriction site marker were linearized with BglII 
(Takara) and transcribed into 5’-capped RNAs using the SP6 
mMESSAGE mMACHINE kit (Ambion Inc). Transcripts were 
precipitated, collected and resuspended as described 
previously (Carrasco et al., 2007).  
To evaluate the neutrality of the five markers, we 
proceeded as follows.  Three 24-week-old N. tabacum cv. Xhanti 
plants were inoculated by abrasion on the third true leaf with 7 
µg of transcribed RNA from each individual marker as 
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described elsewhere (Carrasco et al., 2007). Inoculated plants 
were placed in a BSL-2 greenhouse at 25 ºC and 16 h light/8 h 
dark period. No differences in the time to produce symptoms 
were observed among marked viruses and, in all cases, 
symptoms appeared after 6 – 7 dpi. 
 
2c. Virus quantification and markers neutrality test 
The accumulation of TEV genomes was evaluated by 
quantitative RT-PCR 7 dpi for each engineered genotype as 
described elsewhere (Lalić et al., 2011). RT-qPCRs were 
performed using One Step SYBR PrimeScript RT-PCR kit II 
(Takara) following the instructions provided by the 
manufacturer. The primers forward TEV-CP-qPCR-F 5’- 
TTGGTCTTGATGGCAACGTG-3’ and reverse TEV-CP-qPCR-
R 5’- TGTGCCGTTCAGTGTCTTCCT-3’ amplify a 50 
nucleotides fragment within the TEV CP cistron. CP was 
chosen because it locates in the 3’ end of TEV genome and 
hence would only quantify complete genomes but not partial 
incomplete amplicons. Each RNA sample was quantified three 
times in independent experiments. Amplifications were done 
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using the ABI PRISM Sequence Analyzer 7000 (Applied 
Biosystems). The thermal profile was as follows: RT phase 
consisted of 5 min at 42 °C followed by 10 s at 95 °C; and PCR 
phase of 40 cycles of 5 s at 95 °C and 31 s at 60 °C. 
Quantification results were examined using SDS7000 software 
v. 1.2.3 (Applied Biosystems). 
No differences were observed between markers (Model 
II nested ANOVA, F4,14 = 0.436, P = 0.781) thus confirming their 
neutrality. 
 
2d. Coinoculation experiments and restriction analysis 
Twenty-four-week-old N. tabacum plants were 
mechanically inoculated on the third true leaf with 7 µg of an 
equimolecular mixture of RNA transcripts. The four 
combinations assayed were AscI/PmeI, PmeI/Eco47III, 
Eco47III/SalI, and SalI/SgfI (Figure 2-2). Each combination was 
inoculated on 10 plants. Total RNA was extracted using 
InviTrap® Spin Plant RNA Mini Kit (Invitek) from the 
symptomatic leaves for each of five plants 15 dpi and from the 
other five plants 45 dpi. Each plant was analyzed separately, 
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thus providing independent replicates of the recombination 
rate among pairs of markers. For each combination of 
restriction markers, the regions of interest was reverse 
transcribed using the following reaction mixture: 1× RT 
reaction buffer (Fermentas), 0.2 mM each dNTP, 0.25 μM 
forward primer (Table 2-2), 0.2 μL RNase inhibitor, 40 units of 
MMuLV (Fermentas), 100 ng total RNA, and DEPC-treated 
water to complete 20 μL reaction volume. PCR was then done 
using the following reaction mixture: 1× HF buffer 
(Finnzymes), 0.2 mM each dNTP, 0.25 μM each primer (Table 
2-2), 0.5 units of ultra high-fidelity Phusion DNA polymerase 
(Finzymes), 1 μL DMSO, 3 μL from the reverse-transcription 
reaction, and DEPC-treated water to complete a reaction 
volume of 25 μL. The cycling conditions were: 1 min at 98 ºC; 
followed by 30 cycles consisting of 8 s at 98 ºC, 25 s at 57 ºC and 
25 s/kb at 72 ºC; and then a final extension of 5 min at 72 ºC.  
PCR products were gel purified with GeneJET™ Gel Extraction 
Kit (Fermentas), cloned into the plasmid pUC19/SmaI 
(Fermentas), and used to electro-transform E. coli DH5α. A 
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number of clones per infected plant were purified for 
subsequent restriction analyses (range 15 – 148, median 43). 
Finally, after linearizing the recombinant plasmids with 
KasI (Takara), recombinant clones were genotyped by digestion 
with the corresponding pair of restriction enzymes. The 
expected restriction profiles are shown in Figure 2-2B. For each 
pair of markers, four progeny genotypes are expected, the two 
parentals (Figure 2-2B, left column) and the two recombinants 
(Figure 2-2B, right column). 
 
2e. Statistical analyses 
The frequency of recombinant genotypes on each 
analyzed plant was estimated using the Laplace’s point 
estimator for the Binomial frequency parameter (Chew, 1971) ! = !"#$%&'()(*+!!!"#$%&'()(*+!!"#$%&"'(!!. 
This method provides more robust estimates than the 
commonly used maximum likelihood estimator when sample 
sizes are small. Recombination rates, r, between restriction 
markers were then computed according to Kosambi (1944) 
formula 
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! = !!! ln !!!!!!!!, 
where L is the physical distance separating the two markers (in 
nucleotides). The units of the resulting estimate are 
recombination events per site (r/s). The Kosambi method was 
chosen to minimize the potential effect that multiple crossovers 
may have in the inference of r. The independent estimates for 
each pairs of markers were averaged and the corresponding 
SEM computed. 
A genome-wide r was computed averaging all estimates 
obtained from different combinations of restriction markers 
and experimental replicates. Finally, since TEV produces an 
average of ca. three generations per day in N. tabacum (Tromas 
and Elena, 2010), recombination rate can be expressed as 
recombination events per site and generation (r/s/g), rg. 
All other statistical analyses reported have been 
performed using IBM SPSS version 19. 
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Figure 2-2. (A) Location of the different restriction site 
markers in TEV genome. (B) Expected restriction profile for 
each pair of markers. The left column shows the two parental 
genotypes and the right column the two recombinant ones 
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Restriction 
enzyme 
Cistron Genomic 
position 
for the cut 
Mutagenesis 
primer (5’ to 3’) 
AscI P1 402 TTATCTTGGTCGGCGCGC
CCTCACCCATGGC 
PmeI CI 3735 AGCCTTCCTGGAGTCAC
GTTTAAACAATGGTGGA
ACAACCA 
Eco47III CI 4969 AGTCATACATGACAAGC
TGAAACGTTTTAAGCTAC
ACACTTGTGAG 
SalI NIb 7166 GATGGGAGCATATAAGC
CAACCCGACTTAATAGA
GAGGCG 
SgfI 3’UTR 9463 CTTAGGCGAACGACAAA
GTGCGATCGCCTCGGTCT
AATTCTCCTAT 
Table 2-1. Artificial restriction sites engineered as genetic 
markers for this study. Restriction sites are underlined. 
Mutagenized sites are indicated with bold cursive type. 
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Combination 
TEV genome 
position (5’) Sequence (5’ to 3’) 
AscI/PmeI 46 GCAATCAAGCATT
CTACTTC 
 3894 ATCCAACAGCACC
TCTCAC 
PmeI/Eco47III 3541 TTGACGCTGAGCG
GAGTGATGG 
 5275 CTATTGATGCATG
CTAGAGTC 
Eco47III/SalI 4972 TTAAGCTACACAC
TTGTGAGAC 
 7394 TTCTTTCTTCTTGC
CTTTG 
SalI/SgfI 7058 CACAAAGCATGTG
GTTAAAG 
 9492 CGCACTACATAGG
AGAATTAG 
Table 2-2. Primers used to amplify the region containing the 
pair of restriction sites. 
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3. Estimation of the multiplicity of infection (MOI) 
during RNA virus dynamic infection in a multicellular 
host 	  
3a. Construction of TEV-Venus and TEV-TagBFP 
Infectious plasmid pMTEV (Bedoya and Daròs, 2010) 
containing TEV genome (GenBank accession DQ986288) was 
used to construct the TEV-Venus and TEV-TagBFP genotypes 
in which these two fluorescent marker genes were inserted 
between TEV P1 and HC-Pro cistrons. Venus or TagBFP cDNA 
(Bedoya et al., 2012) was amplified by PCR using primers 
forward 5’-ATGGTGAGCAAGGGCGAGGAG-3’ and reverse     
5’-
TTGGAAGTACAAGTTTTCTCCGCCCTTGTACAGCTCGTCC
ATGC-3’ (Venus), or forward 5’-
ATGAGCGAGCTGATTAAGGAG-3’ and reverse 5’-
TTGGAAGTACAAGTTTTCTCCGCCATTAAGCTTGTGCCCC
AGTTTG-3’ (TagBFP). The reverse primers inserted two 
glycines, as spacers, and a partial NIa-Pro proteolytic site 
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downstream of Venus or TagBFP sequences. This partial 
proteolytic site (ENLYFQ) is complemented by the first 
contiguous serine in HC-Pro cistron to mediate marker release 
from the viral polyprotein. The pTV1a vector, which contains 
the first 3221 nucleotides of the TEV genome including the 
complete P1 to HC-Pro cistrons, was amplified using the 
forward primer 5’-AGCGACAAATCAATCTCTGAGGC-3’ and 
reverse primer 5’-TTTGTCGCTATAATGTGTCATTGAG-3’. 
The PCR-amplified Venus and TagBFP sequences were then 
ligated into the amplified vector sequence, and transformed 
into electrocompetent E. coli DH5α. The identity of the resulting 
pTV1a-Venus and pTV1a-TagBFP plasmids was checked by 
restriction digests and sequencing. Finally, PauI-AatII 
restriction fragments from pTV1a-Venus and pTV1a-TagBFP 
were ligated into PauI-AatII digested pMTEV to construct 
pTEV-Venus and pTEV-TagBFP. All PCR reactions were 
performed with high fidelity Phusion DNA polymerase 
(Finnzymes). 
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3b. In vitro RNA transcription and Inoculation 
TEV-Venus and TEV-TagBFP infectious plasmids were 
linearized with BglII (Takara) and transcribed into 5’-capped 
RNAs using the SP6 mMESSAGE mMACHINE kit (Ambion 
Inc). Transcripts were prepared as described previously. Four-
weeks-old N. tabacum cv. Xanthi plants were mechanically 
inoculated on the third true leaf with RNA TEV transcripts 
mixes (10 µg). Plants were maintained in the green house at 25 
°C and 16 h light for one week. Infected tissues were collected 7 
dpi. Stocks of infectious virions obtained from freshly TEV-
Venus and TEV-TagBFP infected N. tabacum cv. Xanthi were 
used as source of TEV inoculum for our experiments. 
 
3c. Experimental design 
Concentrated saps of TEV-Venus and TEV-TagBFP were 
obtained grinding 500 mg of infected tissue in a mortar with 
800 µL of grinding buffer (50 mM potassium phosphate pH 7.0, 
3% polyethylene glycol 6000). Viruses were inoculated	  
separately, or by a 1:1 mixture of infectious saps on N. tabacum 
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cv. Xanthi plants four-weeks-old. Inoculation was performed 
by abrasion of the third true leaf with 15 µL of each infectious 
sap. To verify the equal proportion of both genotypes in the 
mix, fluorescence was observed after 3 dpi with a Leica MZ16F 
stereomicroscope, using a 1× objective lens with GFP2 filter 
(Leica) for TEV-Venus and Violet filter (Leica) for TEV-TagBFP 
to count foci of primary infection on the inoculated leaf. Plants 
showed equal levels of primary infection for both viruses. 
Protoplasts were then extracted from the inoculated leaf 
(number 1) and from the systemic infected leaves (numbers 3, 4 
and 5 which is the youngest leaf) of five N. tabacum cv. Xanthi 
plants after 3, 5, 7, 10, and 13 dpi. 
 
3d. Protoplasts extraction and fluorescence analysis by 
flow cytometry 
Protoplasts extraction was performed following an 
adaptation of Sankara Rao and Prakash (1995) method. In short, 
sliced leaves were incubated overnight with enzymatic solution 
(0.04% cellulase and 0.015% of pectinase, from Sigma Aldrich; 
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MS 4.3 g/L, 0.6 M manitol, pH 5.8) in dark at 22 ± 2 °C. The 
incubated solution containing protoplast was filtered and 
centrifuged (4 min at 700 rpm). Protoplast were selected by 
sucrose gradient (21%sucrose, MS 4.3 g/L), washed (10 mM 
HEPES, 5 mM CaCl2, 150 mM NaCl, 0.5 M manitol, pH 7) and 
conserved in a hormone solution (MS 4.3 g/L, 0.5 M manitol, 
pH 5.8, 1 mg/L NAA and 0.1 mg/L BAP). Analysis of the 
protoplast was done by flow cytometry (Gallios cytometer, 
Beckman Coulter, CA). This instrument is equipped with a Blue 
Solid State Diode, 488 nm/22 mW and a Violet Solid State 
Diode, 405 nm/40 mW, two detectors for light scattering 
(forward scatter FS and side scatter SS) and ten fluorescence 
detectors. In order to collect the whole FS signal from the 
protoplasts we have to use a neutral density filter to decrease 
10-fold the FS signal. The FS signal provides a measure of cell 
size: large cells show a high FS signal. The SS signal provides a 
measure of cell granulometry: dead cells show low, close to 
null, SS signal. The selection for live protoplasts was performed 
using the chlorophyll fluorescence detected in the 670 nm 
channel (FL4). The more positive cells (live protoplasts) were 
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selected by size, granularity and chlorophyll content. Then, a 
selection of single cell using “time of flight” 
(FSPeaklin/FSTOFlin) was performed to separate aggregates 
from single protoplasts. Venus and TagBFP contents were 
measured, using the 525 nm channel (FL1) and the 450 nm 
channel (FL9), respectively, on each individual protoplast 
selected to quantify the number of TEV-Venus infected, TEV-
TagBFP infected and mixed infected cells. 
 
3e. MOI model fitting and selection 
For model selection, we use the models described in 
Zwart, Tromas and Elena (unpublished manuscript), and an 
additional model (Model 4). These models are all based on the 
Poisson model, but incorporate a number of mechanisms that 
can account for deviations between the data and model. For all 
models the following notation is used: mI is the MOI in infected 
cells (González-Jara et al., 2009), with a range [1, ∞); mT is the 
MOI in all cells, including uninfected cells (Gutiérrez et al., 
2010), and has a range [0, ∞); pA is the frequency of TEV-Venus 
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(A), whereas pB is the frequency of TEV-BFP (B), which can be 
estimated as:  !! = 1 − !! =! ! ! + ! ! ! ! ! ! + ! ! ! + 2! ! ! , 
where f(·) represents the experimentally-observed frequencies 
of cells infected by none, one or both marked virus variants. 
 
MOI model 1: 
This model was developed in Gutiérrez et al. (2010), and 
assumes that MOI follows a Poisson distribution over cells such 
that Pr ! = ! = !!! !!!! !! . It follows that frequency of 
mixed-variant infections is then Pr ! ! = 1 − !!!!!! 1 − !!!!!!    (3), 
where Pr(·) is the expected probability that cells infected by 
none, one or both marked virus variants will be observed. 
There are no model parameters that need to be estimated. MOI 
is assumed to follow a Poisson distribution and therefore an 
inextricable relationship between the fraction of uninfected 
cells, Pr ! ∪ ! , and the mean of the distribution exists: !! =   −!" Pr ! ∪ !      (4). 
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MOI model 2: 
Model 2 allows for spatial segregation of genotypes 
during virus expansion. The model assumes that as infection 
progresses some tissues are only invaded by one viral variant. 
The fraction of the infectious tissue in which both viral variants 
are present, and hence in which coinfection can occur, 
decreases constantly over time and hence: Pr ! ! = !!!" 1 − !!!!!! 1 − !!!! !!!! , 
where ϕ determines the rate of spatial segregation and t is time 
post inoculation in days. Equation 3 still holds for this model, 
and only one parameter needs to be estimated: ϕ. 
 
MOI model 3: 
This model allows for the possibility that there is not 
perfect mixing of infected and non-infected cells, and that 
virus-infected cells tend to be aggregated. The model 
introduces the infection aggregation parameter Ψ, assuming it 
to be constant for all leaves, and again incorporates the 
infection aggregation parameter Ψ: 
	   105	  
(3) !! =   −!" 1 − Pr ! ∪ ! ! . 
Equation 3 still holds for this model. The only parameter 
to be estimated to fit the model is Ψ. Note that in model 2 the 
distribution of viral variants can be heterogeneous over space, 
whereas there is still perfect mixing of viral infection. In model 
3 there is perfect mixing of viral variants, but there can be 
heterogeneities in viral infection over space. 
 
MOI model 4: 
This model is an extension of MOI Model 3, and 
assumes that each leaf has its own aggregation constant Ψ.  
Four parameters must be estimated to fit the model: Ψ1, Ψ3, Ψ4 
and Ψ5. 
 
MOI model 5: 
This model relaxes the assumption of independent 
action by virions by allowing for the effects of super-infection 
exclusion:  Therefore, the MOI is: !! =   −!!!!"!" Pr ! ∩ ! , 
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where ω determines exclusion effects at at t = 0, whilst µ 
controls the rate of change. Equation 3 still holds for this model. 
 
MOI models 6-9: 
We then combined the different models, in order to 
ascertain whether a combination of mechanisms could explain 
the data best. Model 6 combines models 2 and 4, model 7 
combines models 4 and 5, model 8 combines models 2 and 5, 
and model 9 combines models 2, 4 and 5. No combinations with 
model 3 were tested, because model 4 incorporates the same 
mechanism and is much better supported by the data. 
 
Model fitting, model selection and MOI estimates: 
In order to perform model fitting and selection, we 
exploit the fact that for each model there is a relationship 
between the fractions of uninfected and mixed-variant-infected 
cells.  I.e., Equation 3 is used to predict mT, which substituted 
into Equation 4 allows for a prediction of the frequency of 
mixed-variant infection. The likelihood of a particular 
probability of coinfection is then: 
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! Pr ! ! !! ,!! = !!!! !!!" ! ! 1 − !! !!!!" ! !  (6) 
where Dk is the number of mixed-variant infected cells 
observed and Ak is the total number of valid observations made 
by flow cytometry. Model selection was again performed using 
AIC. For the best fitting model (model 4), we predicted MOI 
(mT) with Equation 5. To calculate mI values from mT, we used 
the relationship between the means of a zero-truncated and a 
non-truncated Poisson distribution (Olkin, 1994): !! = !!!!! !!! − 1 . 
 
4. Evolution in case of genetic and functional 
redundancy in an RNA virus 	  
4a. Virus genotypes 
The pTEV7DA infectious clone (Dolja et al., 1992) was 
used as source for TEV. An infectious plasmid containing TEV 
genome lacking the full RNA-polymerase gene (ΔNIb) was 
produced as described in paragraph 1. The rate and spectrum of 
spontaneous mutations in a plant RNA virus. Both TEV and TEV-
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ΔNIb were used to inoculate the transgenic Nt::NIb line of N. 
tabacum cv. Samsung (Li and Carrington, 1995). These 
transgenic plants express TEV NIb protein in a stable and 
functional manner. The presence of the transgene was 
previously confirmed (Tromas and Elena, 2010). 
 
4b. Experimental evolution protocol 
Infectious plasmids pTEV7DA and pTEV7DA-ΔNIb 
were linearized with BglII (Takara) and transcribed into 5’-
capped RNAs using the SP6 mMESSAGE mMACHINE kit 
(Ambion Inc). Transcripts were prepared as described 
previously. Two batches of five four-week-old Nt::NIb plants 
were inoculated mechanically on the third true leaf either with 
TEV transcripts (4 - 7 µg) in inoculation buffer  and TEV-ΔNIb 
trancripts (20 - 25 µg) in the same inoculation buffer. In all case, 
the first symptoms appeared 6 - 7 dpi. 
Two different experiment were performed (Figure 4-1): 
Experiment 1: Thirty weekly passages of TEV and TEV-
ΔNIb viruses were performed in Nt::NIb plants. Every 7 dpi, 
virus were extracted from symptomatic leaves of each of the 
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five lineages per genotypes. 500 mg of symptomatic tissue were 
ground in 500 µL of grinding buffer. 10 µL of the resulting sap 
was then mixed with inoculation buffer and used to infect a 
batch of five healthy transgenic plants by abrasion for each TEV 
genotype. 
Experiment 2: Four 3-weeks-passages of TEV and TEV-
ΔNIb virus were performed in Nt::NIb plants. Every 21 dpi, 
virus were extracted from symptomatic leaves of each of the 
five lineages per genotypes. Infectious sap was prepared as 
described above. 
 
4c. TEV genomic RNA extraction and purification for 
sequence analysis 
Total RNA was extracted using RNAeasy Plant Mini Kit 
(Quiagen) from symptomatic leaves of five Nt::NIb infected by 
TEV and five Nt::NIb infected by TEV-ΔNIb. 
Experiment 1: The full genome was reverse transcribed 
using MMuLV RT (Fermentas) and primers 97-101-R, 67-77-R, 
and 40-45-R and PCR amplified using the high fidelity DNA 
polymerase Phusion (Finnzymes) and 3 pairs of primers 2-10-
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F/40-45-R, 45-48-F/67-77-R, and 73-80-F/97-101-R (Table 4-3). 
By using these pairs we ensured that the mRNA from the 
transgene was not amplified and that we obtained only TEV 
sequences from viral genomes. For both genotypes, TEV and 
TEV-ΔNIb, the three amplicons were purified and sequenced 
by GenoScreen using BIGDYE 3.1 and a 96-capillars ABI3730XL 
sequencing system (Applied Biosystems) with overlapping 
readouts using the same set of primers as in Agudelo-Romero 
et al. (2008). Contigs were assembled using GENEIOUS version 
4.8. 
Experiment 2: To verify the presence of deletions, the 
full genome of each genotype was reverse transcribed using 
MMuLV RT (Fermentas) and primer 97-101-R, then PCR 
amplified using the ultra high fidelity DNA polymerase 
Phusion (Finnzymes) and primers 73-80-F and 97-101-R (Table 
4-3). Deletions were confirmed by size analyses in 1% agarose 
gels. 
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4d. Virus quantification 
We first performed RT-qPCRs assays to compare viral 
accumulation of TEV and TEV-ΔNIb genotypes. RT-qPCRs 
were performed as previously described in paragraph 2. 
Estimation of the in vivo recombination rate for a plant RNA virus. 
 
4e. High-throughput sequencing and data analysis 
To analyse the diversity of deletions that could occur in 
NIb gene during Experiment 2, the full genome of each 
genotype was reverse transcribed using MMuLV RT 
(Fermentas) and primer R97-101, then PCR amplified using the 
ultra high fidelity DNA polymerase Phusion (Finnzymes) and 
primers F73-80 and R97-101. This amplification was repeated 
seven times to limit possible PCR artefacts impact on the high-
throughput sequencing. Then, amplicons were sequenced 
(Illumina HiSeq 2000, Genoscreen) using a paired-end (2×100b) 
protocol. The reads obtained were already de-multiplexed, with 
adapters removed. Data were analysed with GSNAP 
(http://research-pub.gene.com/gmap/). GSNAP aligned both 
single-end and paired-end reads. It can detect short- and long-
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distance splicing, where in our case deletions take place of 
exons. GSNAP was used with its default set of parameters: (i) 
we excluded reads that are mapped on 100 consecutive bases 
on TEV genome. (ii) On the rest of sequences, we searched 
sequences that mapped in two different virus genome regions 
with a minimum of eight bases in 5’ and 3’. (iii) We calculated 
the distance between those regions and to define deletion size 
and position. (iv) We measured the frequency of each found 
deletions. Finally, we obtained the number of reads for each 
deletion variant in R1 and R2 and we compared it to the total 
number of reads for each lineage. 
 
4e. Analysis of mutants of TEV-ΔNIb obtained during 
Experiment 1 
 Each mutant was created “artificially” by site-directed 
mutagenesis using the Quickchange® II XL kit (Stratagene) and 
following the indications given by the manufacturer. Table 4-2 
shows the mutation introduced in a TEV-ΔNIb genotype 
following Stratagene’s recommendations. To minimize 
unwanted errors during the mutagenesis process, the kit 
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incorporates Pfu UltraTM high fidelity Turbo DNA polymerase 
(Stratagene). The amplification conditions were 1 min at 95 ºC 
(initial denaturation), followed by 18 cycles consisting of 30 s at 
95 ºC, 45 s at 65 ºC and 18 min at 68 ºC, and a final extension 
step of 28 min at 68 ºC and a limited number of PCR reaction 
cycles to minimize the chance of appearance of undesired 
mutations. 
Infectious plasmids of each mutant were linearized with 
BglII (Takara) and transcribed into 5’-capped RNAs. 
Transcripts were prepared as described previously. Two 
batches of five 4-week-old Nt::NIb plants were respectively 
inoculated mechanically on the third true leaf with TEV 
transcripts (20 - 30 µg) in inoculation buffer. In all case, the first 
symptoms appeared 6 - 7 dpi. Seven dpi, infectious saps were 
obtained grinding 500 mg of TEV mutants infected tissue in a 
mortar with 500 µL of grinding buffer; then three 4-week-old 
Nt::NIb plants for every TEV mutants were respectively 
inoculated mechanically on the third true leaf with 15 µL of the 
corresponding sap. 
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Finally, after 64 hours post inoculation (hpi), total RNA 
was extracted from the youngest leaves of each of the three 
plants per TEV mutant and then RNAs were purified. RT-qPCR 
was performed to compare viral accumulation of each mutant 
to the TEV-ΔNIb ancestor as described previously. For each 
genotype, a per day Malthusian growth rate was computedas m 
= (1/t) log(Qt), where Qt are the pg of TEV RNA per 100 ng of 
total plant RNA quantified at t = 2.6 dpi. Absolute fitness was 
then defined as W = em (Crow and Kimura, 1970). 
 
Position Type of  Mutation Localization 
3618 G → T 6K1 
3622 A → G 6K1 
3629 C → T 6K1 
6805 A → G NIa-Pro 
6805+3618     
6805+3622     
6805+3629     
Table 4-2. Selected mutants of one-week evolved TEV-ΔNIb. 
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Figure 4-1. Schematic representation of the evolution process 
of TEV and TEV-ΔNIb. 
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Primers 
TEV 
genome 
position (5’) 
Sequence (5’ to 3’) 
45-48-F 3542 TTGACGCTGAGCGGAGTGATGG 
73-80-F 6377 TCATTACAAACAAGCACTTG 
40-45-R 3877 ATCCAACAGCACCTCTCAC 
67-77-R 6664 AATGCTTCCAGAATATGCC 
92-96-R 8762 GCAAACTGCTCATGTGTGG 
97-101-R 9473 CGCACTACATAGGAGAATTAG 
F1 6911 GCAAACCTGAAGAGCCTTTTCAG 
F2 7265 GCATGCTCATCACAAAGCTCAAG 
F3 7591 GTGGATGATTTCAACAATCAATTTTATGAT 
F4 8531 ACCAGCGTCAACACCAGCAC 
F5 8215 GATCTGTCCCATTCCAAAATAGAAAC 
TEV-CP-
qPCR-F 9206 TTGGTCTTGATGGCAACGTG 
TEV-CP-
qPCR-R 9236 TGTGCCGTTCAGTGTCTTCCT 
Table 4-3. Primers used to amplify or to sequence TEV 
genome. 	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RESULTS 	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Chapter 1 
 
The rate and spectrum of spontaneous mutations in a 
plant RNA virus 
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The	  rate of spontaneous mutation is a key parameter to 
understand the genetic structure of populations over time. 
Mutation represents the primary source of genetic variation on 
which natural selection and genetic drift operate. Although the 
exact value of mutation rate is important for several 
evolutionary theories, accurate estimates are only available for 
a handful of organisms. In the case of plant RNA viruses, it has 
been repeatedly reported that their populations are highly 
genetically stable (Fraile et al., 1997; Herránz et al., 2008; Marco 
and Aranda, 2005; Rodríguez-Cerezo et al., 1991;) in comparison 
with their animal counterparts, although reports of higher 
substitution rates also exist (Fargette et al., 2008; Gibbs et al. 
2008). This peculiar behavior might be due in part to stronger 
stabilizing selection, weaker immune-mediated positive 
selection (García-Arenal et al., 2001), the existence of strong 
bottlenecks during cell-to-cell movement and systemic 
colonization of distal tissues (Hall et al., 2001; Li and Roossinck, 
2004; Sacristán et al., 2003;), severe bottlenecks during vector-
mediated transmission (Ali et al., 2006; Betancourt et al., 2008; 
Moury et al., 2007), or differences in the replication mode 
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compared to lytic animal viruses (French and Stenger, 2003; 
Sardanyés et al., 2009). Indeed, the only two available direct 
estimates of mutation rates for plant viruses are both in the 
lower side of the range usually accepted for animal riboviruses: 
0.10 - 0.13 per genome and generation for TMV (Malpica et al., 
2002) and 0.28 for TEV (Sanjuán et al., 2009). However, none of 
these estimates is perfect. Although in the TMV experiments 
particular care was taken to measure mutation rate in a long 
target protected from the action of purifying selection (hence 
deleterious mutations remain in the population), uncertainties 
exist related to the number of infection cycles elapsed during 
the mutation-accumulation phase and the fraction of mutations 
that produced a selectable phenotype. In the case of TEV, the 
estimate should be taken as an upper limit because selection 
was operating during the mutation-accumulation phase. 
Furthermore, the estimate is in the same order of magnitude 
than the methodological error. 
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1a. Characterization of the mutant spectrum 
Table 1-2 summarizes the spectrum of mutations 
characterized for the 472 clones sequenced (724992 
nucleotides). Fifty-two mutations have been identified, 46 of 
which were nucleotide substitutions and six deletions. Four 
hundred twenty-six amplicons had no mutation, 41 carried a 
single mutation and five had two mutations. This distribution 
does not depart from the Poisson expectation (Kolmogorov-
Smirnov test, P = 1). Among base substitutions, 33 were 
transitions and 13 transversions. Consistent with the principle 
that transitions are biochemically more likely than 
transversions, the maximum composite likelihood estimate of 
the overall transitions to transversions rates ratio was 2.161. 
This excess also occurs when purines (4.262) or pyrimidines 
(6.681) are considered separately. Indeed, the observed 
frequencies of transitions among purines and among 
pyrimidines are similar (Figure 1-4) and by far the most 
frequent type of mutation (Table 1-2, Figure 1-4). Therefore, we 
can conclude that TEV polymerase produces, on average, 2/3 
transitions and 1/3 transversions. If purifying selection would 
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not be canceled out by NIb trans-complementation, the ratio 
would be more biased towards transitions because they are 
more often silent. 
Under the observed mutational spectrum, the equilibrium 
base-composition achieved by mutation in the absence of 
selection would be 31.1% A, 25.4% U, 17.8% C, and 25.7% G. 
This distribution significantly deviates from what is expected 
just by sheer chance (χ2 = 55.505, 3 d.f., P < 0.001). The deviation 
is mainly driven by the unbalanced composition in purines, 
with a large excess of A (24.5%) that compensates for the large 
defect in G (−28.9%). 
We have observed that 16 mutations were synonymous 
and 30 were nonsynonymous (including two stop codons). At 
least eight of the nonsynonymous substitutions could induce a 
major deformation on NIb folding by replacing polar or 
charged side chains by apolar ones (E20G, Q462P, H355L, and 
E507A) or apolar side chains by polar ones (F106S, G200S and 
W417R). Three substitutions (L143P, D146H and D276Y) lead to 
a strong change in the side chain length. Nine substitutions 
(D248N, A270V, D276Y, R283Q, I302L, D348N, H355L, T381I, 
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and Q387Stop) may be affecting the putative NIb active site 
(PFAM00680). Among deletions, three involved single 
nucleotides; one involved three contiguous nucleotides. To 
evaluate whether this pattern of synonymous and 
nonsynonymous changes is compatible with a model of neutral 
evolution, we have estimated the difference between 
substitution rates per nonsynonymous (dN) and synonymous 
(dS) sites (using Nei-Gojobori’s modified method and bootstrap 
SEM). The observed value of dN − dS = (5.537±4.133)×10−4 is not 
significantly different from zero (z = 1.340, P = 0.090), failing to 
reject the null hypothesis of neutral evolution and validating 
our methodology for protecting a viral sequence from purifying 
selection. 
 
 
 
 
	   125	  
Type of mutation Number 
Substitution 
matrix 
Total  51  A U G C 
Base 
substitutions 
 46 A - 3 4 7 
 Transitions 33 U 3 - 7 0 
 Transversions 13 G 0 9 - 0 
 Synonymous 16 C 10 2 1 - 
 Nonsynonymous 30 (2 stops)      
Deletions  6      
 1-nt  3      
 3-nt 1      
TABLE 1-2. Numbers of mutations by type and observed 
substitution matrix. 
 
	   126	  
 
Figure 1-4. Observed frequencies for the different types of 
nucleotides substitutions. Each column groups mutations 
rendering complementary pairs and, thus can occur during the 
synthesis of the genomic or antigenomic strains. The LaPlace 
estimator of the frequency has been used to minimize the bias 
due to small sample size (Agresti and Coull, 1998). Error bars 
represent the 95% confidence interval for the estimator. 
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1b. Comparison of TEV mutant spectrum with that 
observed for other plant viruses   
TEV spontaneous mutational spectrum differs in several 
aspects from the other only one reported for plant viruses, 
TMV (Malpica et al., 2002). First, TMV mutational spectrum is 
dominated by insertions and deletions (69% of all mutations 
belong to these categories). Deletions were both short (five 
cases with 1 – 3 nucleotides deleted) and long (seven cases with 
up to 100 nucleotides deleted). Insertions were also short (1 
nucleotide) and large (4 cases with poly(A) insertions). In sharp 
contrast, only 9.8% of mutations in TEV mutational spectrum 
were short deletions, and not a single insertion has been 
observed. This significant difference (Fisher’s exact test, P < 
0.001) suggests either that TEV NIb is more processive in vivo 
than TMV replicase or that the difference is due to the 
experimental setup. In this regard, Malpica et al. (2002) used the 
MP protein expressed in trans as target for measuring mutation 
rate on the viral copy of MP. However, MP has a positive 
regulatory effect on the formation of TMV replication complex 
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(Beachy and Heinlein, 2000) and may favor template switching 
and a higher rate of deletions and insertions. 
The second noticeable difference between both 
mutational spectra refers to the ratio of synonymous to 
nonsynonymous substitutions. TMV ratio is 1:10, whereas for 
TEV it is about five times larger (16:30). This difference may 
reflect that the method employed by Malpica et al. (2002) was 
less efficient than our method to protect deleterious point 
mutations from purifying selection, although this explanation is 
unsatisfactory given the large amount of deletions maintained 
in TMV populations. Nonetheless, it is honest saying that this 
5-fold difference was not statistically significant (Fisher’s exact 
test, P = 0.146). 
A third difference is that the ratio of transitions to 
transversions was roughly 1.0 for TMV whereas it was > 2.0 for 
TEV. Given that it is biochemically easier to produce transitions 
than transversions, the deficit of the former type observed for 
TMV may reflect a preference of its replicase for transversions 
or imperfect sampling (Malpica et al., 2002). 
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Finally, Malpica et al. (2002) found striking the frequency 
of mutant genotypes carrying multiple mutations. The 
distribution of mutations per mutant TMV amplicon had a 
median of one and a range of 1 – 3. In our case, the distribution 
had also a median of one and a range of 1 – 2. From a statistical 
point of view, both distributions are undistinguishable in shape 
(Kolmogorov-Smirnov test, P = 0.199) and location (Mann-
Whitney test, P = 0.929). Therefore, we would not consider 
striking finding a minor proportion of amplicons carrying more 
than one mutation: it is just what is expected from the Poisson 
model. 
 
1c. Estimates of the mutation rate 
Applying the first method described in the Material and 
Methods section, we have obtained 19 independent estimates of 
the spontaneous mutation rate. The estimates ranged from 0 ≤ µ 
≤ 1.340×10−5 m/b/g. The distribution of estimates was Gaussian 
(Kolmogorov-Smirnov test, P = 0.944) with mean  = 4.754×10−6 
m/b/g and standard deviation sµ = 3.540×10−6 m/b/g. As a way 
to evaluate the statistical power associated with this estimate, ! 
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we constructed the 95% confidence interval around the mean as 
3.048×10−6 ≤  ≤ 6.460×10−6 m/b/g, which excludes the zero. 
Therefore, according to these values, we conclude that the 
genomic mutation rate of TEV is 0.045±0.008 (SEM) per 
generation. 
Next, we sought for applying the lethal alleles method. 
To compute the first term in Equation 2, we proceeded as above 
and fitted the observed number of deletions per amplicon per 
plant to a Poisson distribution, obtaining 19 independent 
estimates of µindel. The average rate of deletion mutations was 
µindel = (3.787±1.558)×10−7 deletions/b/r. Next we focused in the 
computation of the second term in Equation 2. Only two out of 
the ∼725 Kb sequenced were stop codons (hence K = 2 in 
Equation 2). As a consequence of codon usage bias, the actual 
number of NSMT in our sample is 7.46% instead of the 
expected 10.34%. Taking this source of bias into consideration 
and after correcting for the three possible nucleotide 
substitutions per site, the second term in Equation 2 results in 
(6.295±0.556)×10−5 m/NSMT/r. Therefore, the estimate of the 
spontaneous lethal mutation rate is µL = (6.299±0.558)×10−5 
! 
µ 
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m/b/r or, expressed into the per genome scale, 0.601±0.053 per 
replication event. 
This µL value is 13.4 times higher than the µ estimate 
obtained using the first method, being the difference highly 
significant (2-samples t-test, t36 = 10.328, P < 0.001). What may 
produce this discrepancy? The lethality method has the 
advantage of being independent from generation time. 
However, it is strongly dependent on whether the mutations 
considered are truly lethal. Deviations from this assumption 
imply that the estimate immediately becomes an upper-limit of 
the true value. In infected cells wherein multiple genomes may 
coexist, genomes carrying deletions or NSMTs can still be 
replicated by the pool of polymerases, encapsidated into wild-
type capsides and moved cell-to-cell and even systemically. In 
other words, complementation with functional proteins makes 
lethal alleles behave as effectively neutral. An alternative 
consideration is that, as defined above, one generation involves 
many replication rounds. Assuming that µL has not been biased 
by complementation, the 13.4 fold difference between estimates 
can be interpreted as the number of replication events within 
	   132	  
an infected cell. Nonetheless, we can conservatively conclude 
that the above µL estimate must be taken as an upper-limit 
estimate of the true mutation rate. 
 
1d. Comparison of TEV mutation rate with those 
obtained for other RNA viruses 
The only previous direct estimate of mutation rate for 
another plant virus, TMV, was in the range 1.452×10−5 – 
2.060×10−5 m/b/g (Malpica et al., 2002), values lying well within 
our two estimates. In a more recent study, Sanjuán et al., (2009) 
estimated TEV upper-limit mutation rate as (2.96±0.32)×10−5 
m/b/g, a value also within our both estimates. In the same 
study, these authors performed a literature survey for upper-
limit estimates of per site mutation rates for four plant viruses. 
All the compiled studies were methodologically similar and 
relied on characterizing the mutant spectrum from individual 
plants inoculated with a viral clone (i.e., close to zero starting 
genetic diversity). In neither of these studies was genetic 
variation protected from purifying selection (Sanjuán et al., 
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2009). The median upper-limit mutation rate estimated was 
7.74×10−4 m/b/g, which was in the range of values estimated 
for animal RNA viruses and some bacteriophages (Drake and 
Holland, 1999) but still 12.3-fold larger than our upper-limit 
estimate. 
Our data allow us to conclude that the mutation rate of 
TEV is slightly lower than previously estimated by Sanjuán et 
al. (2009) and very similar to the only other direct estimation 
available for another RNA plant virus, TMV (Malpica et al., 
2002). 
 
1e. Potential pitfalls and considerations 
In this study we have used a high-fidelity DNA 
polymerase to minimize the probability that observed 
mutations may be due to PCR errors. PrimeSTAR HS DNA 
polymerase is about two times more accurate than Pfu due to 
its improved and robust 3’ → 5’ exonuclease activity and its 
error rate has been estimated to be 1.60×10−6 m/b/PCR cycle 
(catalog.takara-bio.co.jp). Since we run PCRs for 30 cycles, we 
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expect an error rate per amplicon of 4.8×10−5 m/b. Henceforth, 
we may expect ≈ 34 mutations in our sample to be due to errors 
during PCR. Unfortunately, this is not the only source of error; 
the error rate of MMuLV RT is around 3.3×10−5 m/b/r (Arezi 
and Hogrefe, 2007), which means that we may expect as well ≈ 
24 mutations to be produced during retrotranscription. Since 
we have obtained 52 mutations, someone may argue that all of 
them must result from errors during either retrotranscription or 
PCR amplification. This being the case, the mutation rate of 
TEV would be < 10-9 m/b/g, a value that is, by all means, 
absurdly low. Furthermore, the estimate of the error rate of 
PrimeSTAR HS polymerase should be taken with strong 
precaution. It is surprising the manufacturer’ claims that the 
enzyme has improved fidelity compared with Pfu but the 
estimate they provide is undistinguishable from values 
reported for Pfu, 1.3×10−6 m/b/PCR cycle (Cline et al., 1996; 
Bracho et al., 1998). Therefore, we can conclude that even if 
unwanted mutations are produced during the RT-PCR 
amplification, the estimated mutation rates are still on the low 
side of previous reports. 
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Chapter 2 
Estimation of the in vivo recombination rate for a plant 
RNA virus 
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Mechanistically, recombination in RNA viruses can be 
defined as an exchange of genetic material between at least two 
different viral genomes subjected to a replicase-driven 
template-switching action. Various RNA virus recombination 
rates have been quantitatively estimated and showed high 
variability, ranging from 1.4×10-5 recombination events per site 
and generation for HIV-1 within a host (Neher and Leitner, 
2010) to 4×10-8 in the case of HCV (Reiter et al., 2011). Froissart 
et al. (2005) reported the first in planta recombination rate for a 
plant virus during colonization of its individual multicellular 
host for CaMV. They found that recombination for this 
pararetrovirus was frequent and estimated its rate to be 4×10-5 
events per nucleotide site and per replication cycle. 
Unfortunately, in planta estimates for recombination rate of 
single-stranded positive-sense RNA viruses, the most common 
described plant viruses, are still missing. In a very recent 
report, Pita and Roossinck (2013) describe frequent 
recombination events for Cucumber mosaic virus (CMV), but 
their experimental design does not allow performing an 
estimate of the recombination rate. 
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In this study, we provide an estimation of TEV 
recombination rate during a single infection passage in its 
primary hosts N. tabacum. Our strategy was based in 
inoculating equimolecular mixtures of pairs of engineered 
genotypes carrying different neutral markers and 
characterizing the progeny resulting after the systemic infection 
of tobacco plants. Potyviruses represent a particularly 
interesting model system for studying recombination, since two 
confronting observations have been made for this group of 
viruses. On the one side, phylogenetic evidences support 
specially high frequencies of recombination (Chare and 
Holmes, 2005; Reverse et al., 1996). On the other side, it has 
been reported that during mixed infections isolates from the 
same potyvirus form spatial patches in leaves, with no or very 
limited mixing (Dietrich and Maiss, 2003). The question that 
rises is: if different genotypes rarely coinfect the same cell, how 
can recombinant genotypes be so often created? 
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2a. Results of the experiment 
Table 2-3 summarizes the results of the experiment. 
Notice that we failed to produce infection in two of the plants 
inoculated with the mixture PmeI/Eco47III and in one 
inoculated with the mixture SalI/SgfII. Averaging across plants 
infected with the same mixture, the lowest frequency of 
recombinant genotypes was observed 15 dpi for the SalI/SgfII 
pair (f = 2.04%), whereas the largest was observed 15 dpi for the 
AscI/PmeI combination of markers (f = 16.29%). When 
frequencies of recombinant genotypes were transformed into 
recombination rates per site, the lowest value still corresponded 
to the SalI/SgfII pair 15 dpi (r = 8.88×10-6 r/s). However, the 
highest recombination rate was observed for the PmeI/Eco47III 
pair 45 dpi (1.23×10-4 r/s). 
Data were fitted to a GLM using a linear response and 
taking time (dpi) and marker combination as factors. The grand 
mean r was estimated to be (5.90±1.53)×10-5 r/s and 
significantly different from zero (χ2 = 14.857, 1 d.f., P < 0.001). 
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Combination 
Fragment 
size (nt) dpi 
Plants 
analyzed f (±1 SEM) 
r (±1 SEM) 
(×10-5) 
AscI/PmeI 3334 15 5 0.163±0.046 4.886±1.237 
  45 5 0.076±0.047 2.292±1.422 
PmeI/Eco47III 1234 15 4 0.145±0.088 11.893±7.21
8 
  45 4 0.149±0.098 12.247±8.04
1 
Eco47III/SalI 2197 15 5 0.041±0.003 1.867±0.149 
  45 5 0.074±0.020 3.350±0.920 
SalI/SgfI 2298 15 5 0.020±0.000 0.888±0.013 
  45 4 0.037±0.000 1.610±0.000 
Table 2-3. Observed frequency of recombinants and 
recombination rates 
 
2b. Stability of recombination rate along infection time 
No significant time effect was observed neither in f nor 
in r (GLM: χ2 = 0.016, 1 d.f., P = 0.900), thus suggesting that the 
frequency of recombinant genotypes did not increase with time 
after the first 15 dpi. A plausible explanation for this result is 
that the chances for recombination do not increase as infection 
progress and that all recombination events take place early 
during infection. This may be caused by several possible 
mechanisms. One of such mechanisms being that the 
multiplicity of infection (MOI) remains constant after 15 dpi. 
Although this possibility has not been yet explored for TEV or 
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other potyviruses, it was shown that MOI is higher during the 
early stages of the infection and then decreases as infection 
progresses in the case of plant viruses as different as TMV 
(González-Jara et al., 2009) and CaMV (Gutiérrez et al., 2010). 
Since TEV has fully colonized systemic tissues well before 15 
dpi, it is reasonable that MOI would remain more or less 
constant from 15 to 45 dpi. A possible second mechanism to 
minimize the chances of recombination is the above-mentioned 
spatial segregation observed between strains of the same 
potyvirus during mixed infections (Dietrich and Maiss, 2003; 
Zwart et al., 2011, 2012). Obviously, strains carrying each 
marker must coinfect the same cell in order for recombination 
to occur. In such scenario, coinfection will be restricted to the 
very residual number of cells found in the contact edge 
between growing foci. Furthermore, if different leaves are 
colonized by different viral strains, as amply described for 
plant viruses (e.g., French and Stenger, 2005; Hall et al., 2001; 
Jridi et al., 2006), then chances for coinfection will be further 
reduced. 
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2c. Variability in recombination rate along TEV genome 
The above GLM found a significant effect of the marker 
combination in the observed recombination rate (χ2 = 13.103, 3 
d.f., P = 0.004). This difference was entirely driven by the ca. 6-
fold larger recombination rate observed for the PmeI/Eco47III 
genomic region (Table 2-3): 1.58×10-4 r/s versus an average of 
2.62×10-5 r/s across the other three regions. All pairwise 
comparisons involving PmeI/Eco47III were significant (P ≤ 
0.007), whereas all other were not (P ≥ 0.538). The 1215 
nucleotide fragment defined by the markers PmeI and Eco47III 
is entirely within the CI cistron. The CI is an ATP-dependent 
helicase (Laín et al., 1990, 1991) that binds to mature virions and 
promotes cell-to-cell movement via direct interaction with the 
movement protein P3N-PIPO (Vijayapalani et al., 2012; Wei et 
al., 2010). CI helicase has a modular structure formed by seven 
conserved motifs (Kadaré and Haenni, 1997). Modularity may 
facilitate the viability of recombinants CI proteins as far as the 
junctions between modules correspond to the precise sites for 
recombination. This being the case, recombination will bring 
together combinations of modules from different sources, each 
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module retaining its functionality. By contrast, recombination 
in a non-modular protein would result in sequences that may 
not work well together. Unfortunately, GenBank contains not 
enough information on CI intraspecific sequence variability for 
TEV as to test this tantalizing hypothesis. Nonetheless, it is 
interesting that the 5’-terminal half of Turnip mosaic virus 
(TuMV) CI cistron has been previously described as a 
recombination hotspot (Ohshima et al., 2007). 
 
2d. A possible drawback and a solution: unbalanced 
mixtures of markers 
The efficiency of the method we have used to estimate 
recombination rate is strongly dependent on the mixture of the 
two markers being well balanced during infection. We carefully 
quantified and mixed both genotypes to ensure the 1:1 initial 
ratio. However, this ratio may have changed during infection 
for many reasons, e.g. due to subtle fitness differences, or 
because bottlenecks during inoculation or during systemic 
movement. If one of the markers dominates over the other, then 
recombinants will be detected less often than in both markers 
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remain equally abundant. In other words, if the two marked 
genotypes are in proportion 1:1 during the whole experiment, r 
will be properly estimating recombination rate. In contrast, if 
the ratio between both marked genotypes largely deviates from 
1:1 as infection progresses, f will be largely underestimated and 
so does r. Indeed, this effect of unweighted mixtures on the 
estimate of recombination rate has already been reported for 
MMuLV (Anderson et al., 1998). To evaluate the effect of the 
marker composition we plotted each estimate of recombination 
rate against the observed ratio of the less abundant to the most 
abundant parental genotype (Figure 2-3). As shown in Figure 2-
3, the mixtures between both parental strains were not always 
well balanced at the moment of sampling, with ratios spreading 
in the wide range 0.01 to 1. A significant linear regression exists 
between this ratio and r (R = 0.772, F1,35 = 51.699, P < 0.001), 
confirming that the more departure from the hypothetical 1:1 
parental ratio, the lower the estimated recombination rate. The 
regression equation can be used to correct for the effect of the 
unbiased mixtures. In the worse scenario, that is when the ratio 
has the largest possible departure from 1:1 ratio, the 
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(understimated) expected recombination rate is simply a = 
(2.19±1.25)×10-5 r/s (regression model parameters shown in the 
legend of Figure 2-3). By contrast, in the optimal situation, 
namely when the ratio between markers equals one, then the 
expected recombination rate is a + b = (4.50±0.72)×10-4 r/s, that 
is, 7.6 times larger than the genome-average value we reported 
in the previous sections. 
Taking this last number as our best estimate for TEV 
overall recombination rate, and given the observed lack of time 
effect on recombination rate, we can rescale the estimate to the 
more biologically meaningful units of per generation.  Given a 
generation time of 2.91±0.58 generations per day (Martínez et 
al., 2011), 15 dpi are equivalent to 43.65±8.70 generations and 
therefore, rg = (1.03±0.37)×10-5 r/s/g. 
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Figure 2-3. Effect of the mixture bias in the estimate of 
recombination rate. The ratio between the less- and the most-
abundant genotypes is shown in the ordinates axis, whereas the 
observed recombination rates are shown on abscises. Different 
symbols are used for each marker pair. The plot is shown in 
log-log scale to stretch out the data points. The solid line 
represents the regression line a + b×RATIO, whereas the dashed 
lines correspond to the 95% confidence intervals. The 
parameter values (±1 SEM) are: a = (2.190±1.249)×10-5 and b = 
(4.276±0.595) ×10-4. 
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2f. Dealing with the formation of recombinant molecules 
during RT-PCR 
A worrisome aspect of PCR based studies of virus 
variability is the phenomenon of PCR-mediated recombination, 
or chimera formation (Meyerhans et al., 1990). In a recent study, 
Lahr and Katz (2009) have shown that chimera formation was 
minimized by using the Phusion DNA polymerase, no more 
than 30 amplification cycles and, very critical, a low initial 
template concentration. To determine whether the RT-PCR 
conditions used in our experiments may have favor the 
formation of chimeras, we proceeded as follows. First, we 
prepared TEV RNAs by in vitro transcription of the plasmids 
containing the PmeI and Eco47III markers and mixed them in a 
1:1 (w:w) ratio. These markers were chosen for this experiment 
because they show the highest recombination rate. The 
concentration of this RNA mixture was spectrophotometrically 
determined to be 3.92×1011 RNA molecules/μL. Five 10-fold 
serial dilutions of this mixture were made; thus the largest 
dilution contained 3.92×103 RNA molecules/μL. Each of these 
dilutions was then used as template for an RT-PCR experiment 
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(30 cycles, Phusion DNA polymerase). The PCR products were 
purified, cloned, transformed into E. coli, and a number of 
clones per amplification experiment (ranging 28 – 44, median 
35) were analyzed by digestion with PmeI and Eco47III. Figure 
2-4 shows the frequency of chimera molecules as a function of 
the number of TEV template RNA molecules in the RT-PCR 
reaction. The relationship between these two variables is 
sigmoidal: at RNA template concentrations smaller than 
5.46×107 molecules, the estimated inflexion point of the fitted 
curve, no chimeras have been observed. However, for template 
concentrations larger than this critical value, the frequency of 
chimera molecules sharply increases to ca. 50%. 
This result confirms that, all else being equal, the 
concentration of template RNA molecule determines the 
chances of generating chimera molecules during RT-PCR. 
Therefore, the key question now is how many TEV template 
RNA molecules we used in our experiments. The quantitative 
RT-PCR experiments done to test the neutrality of the five 
markers showed that, on average, the concentration of TEV on 
infected plants was of 3.77±0.91 pg per ng of total RNA 
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extracted, which is equivalent to (7.38±1.77)×105 TEV genomes 
per ng of total RNA. Since we seeded our RT-PCR experiments 
on 100 ng of total RNA, this means we added 107 - 108 TEV 
genomes. Therefore, we cannot rule out that our estimates may 
be affected to some extent by PCR artifacts. 
Lets make two additional considerations. First, the 
sigmoidal relationship shown in Figure 2-4 tells that for 107 
template RNA molecules the expected frequency of 
recombinant molecules would be approximately f = 0.23. As 
Table 2-3 shows, the observed f values are all smaller than this 
figure and, therefore, PCR artifacts seem not to be as common 
as suggested in the previous paragraph. Second, if only PCR 
errors would contribute to generate recombinant molecules, 
then observed frequency would be more or less the same 
regardless the pairs of markers used. The observed differences 
among pairs further diminish a possible role of PCR artifacts in 
our observations. 
In conclusion, despite all these considerations, the truth 
is that we cannot completely rule out a possible contribution of 
PCR to the generation of chimeric molecules, we cautiously 
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would consider our estimate as an upper limit value of TEV 
recombination rate. 
 
 
Figure 2-4. Effect of the number of TEV template RNA 
molecules in the formation of chimera molecules during RT-
PCR. The solid line represents the Chapman sigmoidal 
equation ! 1 − !!!×!"# !. The parameter values (±1 SEM) are: 
a = 0.569±0.073, b = 0.840±0.415 and c = 459.521±1444.342 (R2 = 
0.962, F2,3, = 37.650, P = 0.008). 
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2g. Comparison with estimates of recombination rate for 
other plant RNA viruses 
The only previous estimate of recombination rate for a 
plant virus during real infection conditions was reported by 
Froissart et al. (2005) for CaMV, being rg in the range 2×10-5 - 
4×10-5 r/s/g.  This value is in the same order of magnitude than 
our estimation for TEV. 
The recombination rate for the tripartite Brome mosaic 
virus (BMV) has been evaluated in several studies (Bruyere et 
al., 2000; Olsthoorn et al., 2002; Urbanowicz et al., 2005). 
Unfortunately, comparison of these studies and our own one is 
not straightforward for several reasons: (i) none of these studies 
made a rigorous statistical data analyses and just reported 
counts of recombinant and parental genomes, (ii) each study 
focused on a particular genomic region, which may or may not 
be representative for the whole genome, and (iii) no insight on 
the number of generations per day exist for BMV. Nonetheless, 
it is still possible to compute f and r from the numbers provided 
in different tables and figures of these studies. Bruyere et al. 
(2000) introduced several restriction site markers in BMV 
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RNA3, mixed at equal proportions pairs of markers and 
inoculated them in the non-natural host Chenopodium quinoa. 
Variable numbers of local lesions were analyzed for the 
presence of parental and recombinant genomes. From the data 
contained in their Table 1, and averaging across the four 
experimental replicate, we estimated r = (1.41±0.63)×10-4 r/s. In 
a follow-up study Urbanowicz et al. (2005) used the same 
method (with some minor experimental variations) to estimate 
the recombination rates on RNA1 and RNA2. Using the data 
contained in their Figure 3, we estimated r = (1.74±0.04)×10-4 
r/s for RNA1. Similarly, using the data shown in their Figure 2, 
and averaging across experiments, we found that r = 
(2.49±0.40)×10-4 r/s for RNA2. The results for the three 
segments are homogeneous (Kruskal-Wallis test, H = 2.444, 2 
d.f., P = 0.295) and thus we can estimate an average genome-
wide recombination rate per site for BMV of r = (2.10±0.27)×10-4 
r/s. Interestingly, this value is very much consistent with our 
estimate for TEV. In an additional study, Olsthoorn et al. (2002) 
evaluated the probability of recombination between the 
homologous 3’ non-coding regions of the three BMV genomic 
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segments (i.e., recombination between segments). Using the 
data reported in their Table 1, we calculated r = (1.62±0.15)×10-2 
r/s for this small regulatory region, a value that is significantly 
larger than those observed for BMV coding sequences. 
 
2h. Relationship between mutation and recombination 
rates for RNA viruses 
A previous theory suggested that RNA virus high 
mutation rates are also a likely consequence of the tradeoff 
between fast replication and accuracy (Belshaw et al., 2007; 
Elena and Sanjuán, 2005), then a positive correlation must exist 
between mutation and recombination rates across RNA viruses. 
To test this prediction, we search the literature for RNA viruses 
for which estimates of mutation and recombination rates exist. 
Unfortunately, the set is just limited to the following seven 
cases: HIV-1, HCV, MHV, MMuLV, PV, SNV, and TEV. The 
source of recombination rates values are provided in the legend 
of Figure 2-5, whereas mutation rates for all these viruses were 
taken from Sanjuán et al. (2010). When more than one estimate 
existed for one virus, the average was taken. Figure 2-5 
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illustrates the relationship between mutation and 
recombination rates. A positive correlation exists between both 
traits, which becomes highly significant if the discordant data 
point for HCV is removed from the computation (Spearman’s 
ρ = 1.000, 4 d.f., P < 0.001). Removing HCV may be justified 
because the low recombination rate measured by Reiter et al. 
(2011) has already been questioned by others (González-
Candelas et al., 2011). Therefore, we provide support to the 
hypothesis that TEV recombination rate may be a side effect of 
selection for fast but error prone replication, rather than being 
selected for the fitness advantages it may provide in the long 
run. 
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Figure 2-5. Relationship between mutation and 
recombination rates for seven RNA viruses and retroviruses. 
Mutation rates were taken from Sanjuán et al. (2010).  
Recombination rates were taken from: HIV-1 (Batorsky et al., 
2011; Jezt et al., 2000), HCV (Reiter et al., 2011), MHV (Baric et 
al., 1990), MMuLV (Anderson et al., 1998; Zhuang et al., 2006), 
PV (Duggal et al., 1997; Jarvis and Kirkegaard, 1992; King, 
1988), SNV (Hu and Temin, 1989), and TEV (this study). 
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Chapter 3 
Estimation of the multiplicity of infection (MOI) during 
RNA virus dynamic infection in a multicellular host 
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The cellular multiplicity of infection (MOI) is a key 
parameter for describing the interactions between virions and 
cells, for predicting the dynamics of mixed-genotype infections, 
and for understanding virus evolution. Two recent studies have 
reported in vivo MOI estimates for TMV and CaMV (González-
Jara et al., 2009; Gutiérrez et al., 2010), using different 
approaches to measure the distribution of two virus genotypes 
over host cells. Here, we perform a series of experiments to 
estimate the cellular MOI during TEV infection of tobacco 
taking into account two important parameter in the dynamics: 
space and time. 
We isolated protoplasts from the third, fifth, sixth, and 
seventh true leaf at three, five, seven, and 10 dpi, with five 
replicate plants for each time point. We did not analyze the 
fourth leaf because under the conditions used this leaf does not 
show any infection (data not shown). We subsequently refer to 
these leaves as leaf one (inoculated leaf), three, four and five. 
Flow cytometry was subsequently used to determine which 
cells were uninfected, infected with only TEV-BFP or TEV-
Venus, or infected with both variants (see Materials and 
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Methods). We could therefore quantitatively track the number of 
TEV-infected cells in an infected plant over space and time, for 
two virus genotypes. Then, we used flow cytometry to detect 
the presence of fluorescently labelled virus variants in 
thousands of individual cells and we used model selection to 
identify the best-supported model for making MOI estimates. 
Overall, our data and analyses confirmed that MOI 
estimation methods must take into account differences in 
susceptibility or exposure of cells to virions, whereas there was, 
surprisingly, no evidence for spatial segregation of viral 
genotypes. 
 
3a. Total number of TEV-infected cells over space and 
time 
In contrast to previous reports (González-Jara et al., 2009; 
Gutiérrez et al., 2010), the frequency of virus-infected cells was 
low (mean ± SD: 0.100±0.073), with the highest level of infection 
observed in any sample being 0.306 (leaf four at 7 dpi) (Figure 
3-2a-d). The frequency of cells infected by both virus variants 
was also low (mean ± SD: 0.012±0.023), with the highest level of 
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coinfection observed in any sample being 0.112 (leaf four at 7 
dpi) (Figure 3-2a-d). Prima facie these results suggest that the 
cellular MOI is low, given that if a small number of virions 
infect each cell there will be few cellular coinfections with both 
viral variants. At 3 dpi, few cells were infected in any leaf, with 
the greatest number of infections being found in the leaves one 
and four (Figure 3-2e). This surprising observation can be 
explained by the occurrence of limited, relatively slow TEV 
expansion at the macroscopic level in the inoculated leaf (Zwart 
et al., 2012), combined with fast egress from the inoculated leaf 
to leaf four (Lafforgue et al., 2012). Both infection and 
coinfection appear to increase over time in the different leaves, 
although leaf three only shows very low levels of infection. The 
lack of infected cells in leaf three probably comes about because 
this leaf has already made a sink-source transition, impeding 
access to a phloem-transported virus. Infection progresses 
slower in leaf one than in leaves four and five.  Leaf four 
becomes infected before leaf five, but the dynamics in these two 
leaves appear to otherwise be very similar. These results are 
therefore in good agreement with macroscopic observations of 
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infection dynamics (Dolja et al., 1992; Lafforgue et al., 2012; 
Zwart et al., 2012). 
 
Figure 3-2: Infected cells over space and time. In panels (a-d), 
the observed frequencies of cellular infection in leaves five, 
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four, three and one are given for TEV-Venus only (finely dotted 
green line with circles), TEV-BFP only (coarsely dotted blue line 
with squares) and coinfections with both variants (continuous 
red line with diamonds). The abscissae represents dpi, whilst 
the ordinate is the frequency at which a particular infected-cell 
type was observed. Error bars represent one standard deviation 
for all panels in the figure. Note that leaf two was not included 
because it does not become infected. In Panel (e), the frequency 
of infected cells (TEV-Venus, TEV-BFP and both virus variants) 
at day three is given for different leaves. In Panel (f), the 
frequency of infected cells (ordinate) over time (abscissae) is 
given, for the data pooled from all leaves (black circles). The 
black line indicates a logistic model fitted to the data, whereas 
the brown line indicates a scaled logistic growth curve fitted to 
RT-qPCR data in a similar experiment (Zwart et al., 2012). The 
logistic model fitted the data well, and suggests that in the final 
time point the plant is approaching κ, the carry capacity. The 
RT-qPCR-based curve is surprisingly similar to infected-cell 
curve, although at 5 dpi predicted TEV RNA levels appear to 
be relatively lower than the proportion of infected cells. This 
discrepancy may depend on the methodology used, or there 
may be a large number of cells that are in early infection, when 
the fluorescent marker protein is expressed by viral RNA 
accumulation levels are still low. 
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3b. Cellular MOI estimation 
The cellular MOI can be estimated from our data, as has 
been previously done for two plant viruses with a similar 
experimental setup (González-Jara et al., 2009; Gutiérrez et al., 
2010). Estimates of MOI can, however, be strongly influenced 
by the estimation method (Zwart, Tromas and Elena, 
unpublished manuscript). Model selection was therefore 
performed on a set of nine MOI-predicting models, by testing 
which Poisson-based model best predicted the relationship 
between the fractions of uninfected and mixed-variant-infected 
cells. The models incorporated spatial segregation of virus 
genotypes, spatial aggregation of infected cells, coinfection 
exclusion at the cellular level and combinations of these effects. 
We could thereby identify the best model to make MOI 
estimates (Tables 3-1 and 3-2). 
The best-supported model incorporated a leaf-
dependent aggregation factor ψ (Table 3-2) suggesting that the 
aggregation of virus-infected cells is a key element for 
describing MOI. Infected cells are probably aggregated by 
virtue of their immobility and because TEV spreads by cell-to-
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cell movement within a leaf. Surprisingly, models 
incorporating spatial segregation of genotypes were never 
selected. Our results therefore suggest that although virus-
infected cells are clearly aggregated, the lower than expected 
rates of mixed-variant infections are not due to aggregation of 
different viral variants. In other words, aggregation in viral 
infection disrupts the Poisson-based relationship between the 
fractions of uninfected and mixed-variant-infected cells 
observed, whilst the well-mixed assumption for viral genotypes 
is never rejected during the course of infection. 
We then derived predictions of MOI using the best-
supported model (Figure 3-3a). As could be expected from the 
low rates of cellular infection and mixed-variant infection 
(Figure 3-2a-d), the predicted MOIs were low, ranging from 
1.006 (leaf three, 3 dpi) to 1.646 (leaf four, 7 dpi). Note that we 
report the estimated MOI value in infected cells only (i.e., mI in 
Materials and Methods), which has a minimum value of 1. The 
corresponding range of MOI values calculated over the whole 
population of infected and uninfected cells (mT) is 0.012 (leaf 
three, 3 dpi) to 1.071 (leaf four, 7 dpi). To help interpret 
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estimated MOI values, we provide model predictions of the 
frequencies at which cells are infected by a particular number 
of virions, for low, intermediate and high levels of infection 
observed here (Figure 3-3c-e). 
 
 
Figure 3-3: Cellular MOI. Panel (a) gives estimates of ψ, the 
leaf-dependent infection aggregation parameter, for the best-
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supported model. Panel (b) gives estimates of cellular MOI, for 
different times post inoculation and in different leaves. Note 
that the reported MOI value is mI, the MOI in infected cells 
only, which has a minimum value of 1. MOI is initially very 
low and gradually increases, never reaching 1.7. MOI values for 
the final timepoint (10 dpi) are similar for leaves one, four and 
five, whilst remaining very low for leaf three, which hardly 
becomes infected. In panels (c-e), model predictions for the 
frequency at which cells are infected by a certain number of 
virions is given. The blue section of the bar indicates the 
frequency of infection by only one virus variant, whereas 
striped area indicates mixed-variant infection, assuming a 1:1 
ratio of virus variants. Panel (c) gives this prediction for the 
lowest MOI value (mI = 1.006), panel d for the mean MOI (mI = 
1.171), and panel e for the highest MOI value (mI = 1.646).  
Estimated MOI values are low, but the number of infecting 
virions is assumed to follow a Poisson distribution.  Hence 
even at the low mean MOI some cells will be infected by 2 or 
more virions, allowing for mixed-variant infections. 
 
Model Parameter estimates [95% CI] 
1 - 
2 ϕ = 0 [0-0.017] 
3 ψ = 0.650 [0.588-0.660] 
4 
ψ1 = 0.288 [0.224-0.314] 
ψ3 = 0.552 [0.487-0.608] 
ψ4 = 0.622 [0.536-0.648]  
ψ5 = 0.694 [0.627-0.716] 
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5 Ω = 1 [*] 
τ = 0 [*] 
6 ϕ = 0 [0-0.063] 
ψ1 = 0.288 [0.224-0.328] 
ψ3 = 0.552 [0.442-0.608] 
ψ4 = 0.622 [0.415-0.646]  
ψ5 = 0.694 [0.446-0.715] 
7 Ω = 1 [*] 
τ = 0 [0-0.018] 
ψ1 = 0.288 [0.249-0.333] 
ψ3 = 0.552 [0.466-0.607] 
ψ4 = 0.622 [0.506-0.648]  
ψ5 = 0.694 [0.581-0.718] 
8 
ϕ = 0 [0-0.014] 
Ω = 1 [*] 
τ = 0 [0-0.007] 
9 
ϕ = 0 [0-0.060] 
Ω = 1 [*] 
τ = 0 [0-0.002] 
ψ1 = 0.288 [0.242-0.329] 
ψ3 = 0.552 [0.458-0.615] 
ψ4 = 0.622 [0.477-0.647]  
ψ5 = 0.694 [0.519-0.716] 
Table 3-1: Estimated model parameters  
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Model Parameters NLL AIC ΔAIC AW 
1 0 13,173.83 26,347.66 22,314.12 0 
2 1 13,173.83 26,349.66 22,316.12 0 
3 1 2560.25 5112.50 1088.96 0 
4 4 2012.77 4033,54 - 0.644 
5 2 13,173.83 26,351.66 22,318.12 0 
6 5 2012.77 4035,54 2.00 0.237 
7 6 2012.77 4037,54 4.00 0.087 
8 3 13,173.83 26,353.66 22,320.12 0 
9 7 2012.77 4039.54 6.00 0.032 
Table 3-2: Model selection. Results of model selection using 
the Akaike Information Criterion (AIC). Model refers to the 
model number in Materials and Methods, with Model 5 being the 
model discussed in the results section of the paper. Parameters 
is the number of model parameters, NLL is the negative log 
likelihood, AIC is the Akaike Information Criterion, ΔAIC is 
the difference in AIC between the model in question and the 
best fitting model (Model 5), and AW is the Akaike Weight, 
which gives an indication of the probability that a model is best 
supported. Model 4 is the best-supported model. Although 
Models 6, 7 and 9 have similar AIC values and an appreciable 
AW, these models can be discounted since at the estimated 
parameter values (Table 3-1) the model collapses to Model 4.
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Chapter 4 
Evolution in case of genetic and functional redundancy 
in an RNA virus 
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RNA viruses can be defined by two evolutionary 
characteristics: high variability and extremely small and 
compacted genomes. Interestingly, a small genome leads to an 
apparently low complexity, to a lack of replication enzymes 
with fidelity mechanisms and so on to a high variability (Smith 
and Szathmáry, 1995). A clear advantage of a small genome is 
to replicate quick. Consequently, only few examples of host 
genetic material integrated into the RNA genome have been 
observed (Meyers et al., 1989a). When a host gene is inserted 
into a viral genome, RNA genome size increases and would 
lead to mutational load increase and viral fitness reduction 
(Holmes, 2009). Dolja et al. (1993) observed large deletions into 
a foreign gene inserted into the TEV genome. On the contrary, 
it has been recently observed that NIRVs are integrated into 
mammalian (Belyi et al., 2010; Geuking et al., 2009; Horie et al., 
2010; Katzourakis and Gifford, 2010) and plant (Chiba et al, 
2011) genomes. A particularly interesting situation is created 
when hosts carrying a given NIRV are infected by the virus 
from which the NIRV was taken. How would the virus 
population evolve under such situation of functional 
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redundancy? This is the question we want to tackle in this 
study. To do so, we are evaluating the patterns of genomic 
evolution of TEV in N. tabacum transgenic plants expressing 
TEV replicase NIb (Li and Carrington, 1995). 
During infection of transgenic plants, the NIb copy 
coded by TEV genome is redundant with the polymerase 
produced by the transgenic plant and thus should experienced 
relaxed selection. As a redundant gene, we hypothesize that 
partial or total deletion of viral NIb gene could occur after 
several serial passages. In a second evolution experiment, we 
anticipate this deletion and study how a TEV-∆NIb evolves 
when complemented in trans by the NIb protein expressed by 
the plants. In both cases, how would such a big genomic 
perturbation affect the regulation of expression and 
accumulation of all other viral components? 
 
4a. Comparison between TEV and TEV-∆NIb 
accumulation in transgenics plants 
In a previous study, Li and Carrington (1995) showed 
that TEV-∆NIb can be complemented in trans by the NIb protein 
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expressed by the plants and they demonstrated that at 8 dpi, 
GUS activity in leaves systemically infected by the TEV-∆NIb-
GUS mutant was comparable to the activity level of parental 
TEV-GUS. We have confirmed this result by RT-qPCR (Figure 
4-2), and no significant differences were observed in virus 
accumulation between TEV and TEV-∆NIb in transgenic 
Nb::NIb plants (t8 = 1.394, P = 0.201). After 30 one-week 
passages, no significant differences were noticed between the 
ancestral TEV and the TEV lineages isolated at the end of the 
evolution phase. On the contrary, three lineages of TEV-∆NIb 
showed a lower viral accumulation than the ancestral TEV-
∆NIb (Mann-Whitney test, P < 0,05) (Figure 4-3). Then, these 
results suggest that the use in trans of NIb produced by the 
plant could affect virus accumulation of TEV-∆NIb genotypes 
after several short-time passages. 
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Figure 4-2. Virus accumulation by absolute quantification of 
TEV vs TEV-∆NIb in N. tabacum::NIb after one passage. No 
significant difference in the accumulation of TEV and TEV-
∆NIb was observed. 
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Figure 4-3. Virus accumulation by absolute quantification of 
TEV vs TEV-∆NIb in N. tabacum::NIb after 30 passages. 
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days intervals resulted in a good stability of each genotype over 
30 passages. 
No difference was noticed between ratios of transitions 
to transversions; ratios were 7 for TEV and 6 for TEV-∆NIb. 
Given that it is biochemically easier to produce transitions than 
transversions, it is not surprising to observe these biased ratios. 
The first noticeable difference between both mutational 
spectra refers to the ratio of synonymous to non-synonymous 
substitutions. TEV ratio is 11:5, whereas for TEV-∆NIb it is 
about four times lower (7:11), although the difference between 
viruses was not significant (Fisher’s exact test, P = 0.100). 
For both genotypes, mutations were spread equally 
among the genome (Figure 4-4) and only one mutation was 
shared by both genotypes. Indeed, the mutation A6805G 
(K2269E) localized in NIa-Pro was observed 4/5 lineages of 
TEV genotype and in 2/5 lineages of the TEV-∆NIb genotype. 
This non-synonymous mutation; localized in the extern face of 
the NIa protein could affect the NIa protease; interfering in a 
putative interaction with other protein.  
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Of particular interest are three non-synonymous 
mutations localized in the 6K1/CI junction (Figure 4-5): 
G3618U (E1206D), A3622G (I1208V), and C3629U (T1210M), 
affecting residues P6, P4 and P2 of the proteolytic site, 
respectively (Adams et al., 2005a). 
Previous study defined a conserved heptapeptide 
sequence [E-X-X-Y-X-Q/S (or G)] at the 6K1/CI junction 
(Adams et al., 2005a; Carrington and Dougherty, 1987, 1988; 
Carrington et al., 1988). As described in Figure 4-5, these three 
mutations were observed after 30 one-week passages in 
position P6, P4 and P2. Each mutation was obtained in one 
lineage but none lineage got all the three mutations together. 
E1206D conservative mutation at P6 site should affect weakly 
the proteolytic processing as amino acids E and D are widely 
represented in Potyviriade family at this site (Adams et al., 
2005a). On the contrary, P4 Mutation I1208V at position P4 
should have a stronger impact on processing activity. Indeed, I 
is represented in position P4 at a low frequency of 7% among 
all Potyviridae, whereas V is extremely common (80%) (Adams 
et al., 2005a). Another mutation that could affect protease 
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processing is T1210M in P2; being M rare among the Potyviridae 
(2%). Generally, mutation on P2/P4 may involve regulation of 
the cleavage rate (Dougherty et al., 1989). 
 
 
 
Figure 4-4. Mutations in TEV (B) and TEV-∆NIb (A) evolved 
genome after 30 weekly passages in Nt::NIb plants. Black 
circles represent synonymous mutation, grey circles the non-
synonymous mutation and white circle mutations localized in 
UTR. 
 
 
 
Figure 4-5. TEV-∆NIb mutations on the NIa-Pro proteolytic 
6K1/CI site. P6 to P2’ (E-x-x-Y-x-Q-G/S) are key amino acids 
constituting the NIa-Pro binding site. Cleavage site is between 
P1 and P1’. P6: E (26.5%) and D (12.8%) are the most frequent 
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amino acids at this position in the family Potyviridae; P4: V is 
the most frequent 80%; P2: H (40%) and F (15%) are the most 
represented in Potyviridae, M is represented with a frequency of 
only 2%. Generally, mutations at positions P2/P4 may involve 
regulation of the cleavage rate (Dougherty et al., 1989). 
 
TEV type of mutation   TEV-∆NIb type of mutation  
Total 16  Total 21 
Base substitution 16  Base substitution 21 
Transitions 14  Transitions 18 
Transversions 2  Transversions 3 
Synonymous 11  Synonymous 7 
Non-synonymous 5  Non-synonymous 11 
UTR 0  UTR 3 
  A U G C 
A _ 0 2 0 
U 2 _ 0 2 
G 6 0 _ 0 
C 0 4 0 _ 
 
 
   A U G C 
A _ 0 9 0 
U 0 _ 0 3 
G 4 1 _ 0 
C 1 3 0 _ 
 
 
TABLE 4-4. Mutation spectrum and substitution matrix for 
TEV and TEV-∆NIb evolved genome after 30-one-week 
passages in Nt::NIb plants 
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4c. Analysis of a selection of TEV-∆NIb mutant after 
thirty weekly passages 
The different mutants K2269E, E1206D, I1208V, and 
T1210M were generated by site-directed mutagenesis on the 
infectious plasmid pMTEV. In addition, since K2269E is 
common among different lineages, we also produced this 
mutation in combination with the other three. As a proxy to the 
fitness effect of these mutations, viral accumulation of each 
simple and double mutant was determined 64 hpi by RTq-PCR 
in 3 replicates. 
Data were fitted to a GLM using “genotype” as factor 
and “biological replicate” nested within “genotype”.  A 
significant effect of the mutant in the observed viral 
accumulation (χ2 = 134.648, 7 d.f., P < 0.001) and a Bonferroni 
sequential post hoc test found four different homogenous 
groups (Figure 4-6), A being the group with the lowest viral 
accumulation value and D the highest. 
Group A was formed by the original TEV-∆NIb and 
mutant E1206D (affecting the P6 position of 6K1/CI proteolitic 
site). Interestingly this result is consistent with our previous 
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hypothesis. Group B showed higher accumulation values and 
was formed by genotypes carrying mutations at positions P4 
and P2 of the 6K1/CI proteolytic site. Both groups C and D 
carry mutation K2269E at the NIa-Pro. This mutation confers a 
significantly higher accumulation to the TEV-∆NIb than 
mutations of the A and B group. Very interestingly, double 
mutants carrying K2269E and the corresponding mutations 
affecting the P6 or P4 (group D) showed the highest viral 
accumulation levels.  Thus, we conclude that the NIa-Pro 
mutation K2269E observed in different evolved lineages of 
TEV-∆NIb must confer a fitness advantage to the TEV-∆NIb 
when combined with mutations affecting important residues of 
the proteolytic site. 
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Figure 4-6. Accumulation of mutants E1206D, I1208V, 
T1210M, K2269E and the combinations K2269E/E1206D, 
K2269E/I1208V and K2269E/T1210M. Four groups with 
homogeneous accumulations (groups A to D). 
 
4d. Mutational spectrum of TEV and TEV-∆NIb after four 
three-week passages 
Evolution experiments with longer passages were 
performed for both TEV and TEV-∆NIb genotypes. Following 
Dolja et al. (1993), we expect that these longer passages will 
favor the fixation of more mutations given the increased 
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chances for competition and selection.  A first remarkable 
observation is that no recombination was observed between 
TEV-∆NIb and the transgene that restores the genome 
architecture and gene content of TEV, as previously observed 
for tombusvirus (Borja et al., 1999). A second remarkable 
observation is that the first NIb deletion was observed for one 
TEV lineage after only one passage. Readly, additional 
deletions were detected by RT-PCR after four passages on other 
lineages (Figure 4-7). Each of these deletions conserved the 
reading frame and was situated within the NIb cistron. 
 
 
 
Figure 4-7. TEV and deletion variants detected by RT-PCR in 
different lineages at passages one and four. NIb (6982-8517) is 
rapidly deleted after one three-week passage (TEVp1 n10) in 
NIa                        NIb                       CP                   
6993 8480 
TEV 
TEVp1 n10 
7621 8484 
TEVp4 n4 
7046 8500 
TEVp4 n5 
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only one lineage. After four three-week passages, deletion 
variants are observed in different lineages as e.g. TEVp4 n4 and 
TEVp4 n5. All deletions observed after RT-PCR are situated 
within NIb and retain the reading frame. 
 
4e. High-throughput sequencing of TEV after four three-
week passages 
In order to assess the stability of TEV genotype and its 
tendency to loose the NIb gene during passages in transgenic 
plants Nt::NIb, a NGS experiment was performed on the five 
independent lineages of TEV evolved after four three-week 
passages. The TEV genome region containing NIb cistron (6377-
9473) was amplified and sequenced as described in Materials 
and Methods section. To control the quality of our study, the 
same region from five N. tabacum infected by wild-type TEV 
was also sequenced by NGS and analysed. In these control 
plants, no deletions of NIb were observed. The frequency of 
each deletion variants described in Table 4-5, detected in 
systemically infected leaves of transgenic plants, is 
significantly different to our negative control (Fisher’s exact 
test, P < 0.001). Our results is also consistent with the previous 
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deletion variants identified by RT-PCR, indeed we detected the 
same deletion in lineages four (7621-8484) and five (7046-8500) 
with the highest frequency.  Twenty-two different deletion 
variants were observed, ranging in frequency from 2.597×10-6 
(7445-8341; lineage 6) to 6.665×10-4 (7621-8484; lineage 4). 
Interestingly, all deletion variants have respected the reading 
frame of the coding sequence, meaning that these variant could 
be viable when trans-complemented by the NIb expressed by 
the plant. 
Very surprisingly, in six deletion variants, the deletion 
extended in the 5’ to include part of the NIa-Pro. Also, in other 
six variants, the deletion covered from position 6399 in NIa-Pro 
to position 9282 of CP. These 12 genotypes carrying larger-
than-NIb deletions will produce deffective NIa-Pro and/or CP 
and thus, must act as defective interfering particles. These 
defective particles must be complemented in co-infected cells 
by other TEV virus and their spread must be limited, then their 
frequency in viral population should be lower than ancestral 
and NIb deleted genotypes. Unexpectedly, one NIa-Pro-to-CP 
deletion variant (from positions 6438 to 8984) shows a 
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frequency of 3.13279×10-5, comparable to that of most of NIb-
only deletion variants. Finally, as described in Figure 4-8, all 
lineages except TEV number six are dominated by variants 
with NIb deletion only, which is consistent with the fact that 
these variants are viable. Nevertheless, it is surprising to detect 
so many defective genomes with deletions in NIa-Pro and/or 
CP, which lead to think that coinfection shall be a common 
phenomenon during TEV infection. In agreement with this 
idea, the preservation of defective viral particles by 
complementation has been widely described (Froissart et al., 
2004; García-Arriaza et al., 2004; Moreno et al., 1997; Roux et al., 
1991). 
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Figure 4-8.  Frequency of deletion variants in TEV lineages.  
 
Position 
Deletion  
size Repeats Freq Region Lineage 
6418-9282 2865 16,0 1.63E-05 
NIaPro-
NIb-CP TEVn1 
6569-8746 2178 12,5 1.27E-05 
NIaPro-
NIb-CP TEVn1 
6774-8795 2022 6,0 6.11E-06 
NIaPro-
NIb-CP TEVn1 
7291-8421 1131 15,0 1.53E-05 NIb TEVn1 
6418-8421 2004 8,0 6.39E-06 
NIaPro-
NIb TEVn4 
6448-8463 2016 17,5 1.40E-05 
NIaPro-
NIb TEVn4 
6399-9200 2802 8,0 6.39E-06 
NIaPro-
NIb-CP TEVn4 
7072-8385 1314 6,5 5.19E-06 NIb TEVn4 
7148-8386 1239 7,5 5.99E-06 NIb TEVn4 
7405-8478 1074 54,5 4.83E-05 NIb TEVn4 
7621-8484 864 835,0 6.66E-4 NIb TEVn4 
6457-8385 1929 6,0 5.78E-06 
NIaPro-
NIb TEVn5 
7046-8500 1455 650,0 6.26E-4 NIb TEVn5 
1,0E-06 
1,0E-05 
1,0E-04 
1,0E-03 
NIaPro-NIb-CP NIa-Pro-NIb NIb 
Fr
eq
u
en
cy
 (L
og
) 
TEV1 
TEV4 
TEV5 
TEV6 
TEV7 
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6460-8478 2019 26,5 8.60E-06 
NIaPro-
NIb TEVn6 
6488-8455 1968 8,0 2.60E-06 
NIaPro-
NIb TEVn6 
6590-8374 1785 9,0 2.92E-06 
NIaPro-
NIb TEVn6 
6429-8702 2274 9,5 3.08E-06 
NIaPro-
NIb-CP TEVn6 
6438-8984 2547 96,5 3.13E-05 
NIaPro-
NIb-CP TEVn6 
7155-8483 1329 9,5 3.08E-06 NIb TEVn6 
7221-8480 1260 30,5 1.10E-05 NIb TEVn6 
7445-8341 897 8,0 2.60E-06 NIb TEVn6 
7655-8407 753 7,0 5.09E-06 NIb TEVn7 
 
Table 4-5.  Diversity and frequency of deletions in TEV 
genotype after four thee-week passages in five different 
lineages. 	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DISCUSSION 
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1. The rate and spectrum of spontaneous mutations in a 
plant RNA virus 
Plant RNA virus mutation rate estimates are within a 
narrow range of values in the lower side of estimates reported 
for RNA animal viruses and bacteriophages (Malpica et al., 
2002; Tromas and Elena, 2010). This agreement suggests that 
plant RNA viruses have lower mutation rates than their animal 
counterparts. Indeed, this difference in mutation rates may help 
to partially explain why the rates of molecular evolution of 
most RNA plant viruses are apparently lower than those 
observed for RNA animal viruses (Fraile et al., 1997; Herránz et 
al., 2008; Marco and Aranda, 2005; Rodríguez-Cerezo et al., 
1991). This difference between animal and plant RNA viruses 
raises an intriguing question: given that plant and animal RNA 
viruses do not form separated phylogenetic groups and that 
they are replicated by similar polymerases, why plant RNA 
viruses show lower mutation rates? We can imagine several 
scenarios. First, obviously, this may not be the rule and just by 
chance TEV and TMV turn out to have polymerases of 
particularly good fidelity. A second obvious possibility is that 
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most values for animal RNA viruses are upper-limit 
estimations. In this sense, it has been reported that Yellow fever 
virus polymerase has an error rate as low as 1.9×10-7 m/b/g 
(Pugachev et al., 2002). Third, the difference is real and results 
from differences in the selective pressures that modulated the 
evolution of mutation rates in both types of hosts; this implying 
that mutation rate is higher for animal RNA viruses because 
animals represent a more stressful environment, perhaps in the 
form of more diverse cell types or stronger antiviral responses 
(e.g., the adaptive immune system; Kamp et al., 2002). However, 
whether virus mutation rates have been optimized by natural 
selection or are byproducts of a parasitic fast lifestyle needs to 
be confirmed (Elena and Sanjuán, 2005). 
 
2. Estimation of the in vivo recombination rate for a 
plant RNA virus 
In this thesis we have evaluated the point mutation rate 
for TEV to be in the range 4.754×10-6 - 6.299×10-5 m/s/g, a 
range that, given the uncertainties associated to both estimates, 
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is in the same order of magnitude than the estimate of 
recombination rate here provided. In any case, this similarity 
suggests that mutation and recombination may have a similar 
impact on the generation of genetic diversity for TEV. 
Mutation and recombination rates being on the same 
order of magnitude have important evolutionary implications. 
For example, high mutation rates in combination with small 
population sizes during viral transmission turn on Muller’s 
ratchet, a phenomenon already shown to operate in 
experimental TEV populations transmitted throughout very 
dramatic bottlenecks (De la Iglesia and Elena, 2007). A large 
recombination rate would counter act the effect of Muller’s 
ratchet by recreating mutation-free genomes. This example 
points towards one of the most claimed evolutionary 
advantages of recombination, as a form of sexual reproduction, 
namely the purging of deleterious mutations from populations 
(Muller, 1964; Simon-Loriere and Holmes, 2011). In a similar 
vein, large recombination rates may have also evolved to speed 
up the rate of adaptation by bringing together beneficial 
mutations that otherwise would exist in different genomes, 
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thus minimizing the effect of clonal interference (Fisher, 1930; 
Muller, 1932; Simon-Loriere and Holmes, 2011). In addition to 
these “fitness advantage” theories, other models have been 
brought forward to explain viral recombination. A particularly 
intriguing yet appealing of such theories argues that RNA virus 
recombination may have not evolved because direct fitness 
benefits but simply as a byproduct of the high processivity of 
viral RNA polymerases (Simon-Loriere and Holmes, 2011): the 
faster the replicase moves, the more slippery it is and the more 
likely to suffer a jump to a different template. If the tradeoff 
between fast replication and accuracy induced RNA virus high 
mutation rates as previously suggested (Belshaw et al., 2007; 
Elena and Sanjuán, 2005); the same correlation could be done 
for the RNA virus recombination rates. A positive correlation 
was defined between mutation and recombination rates across 
RNA virus and could open new perspective to understand the 
evolution of recombination rates. 
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3. Estimation of the multiplicity of infection (MOI) 
during RNA virus dynamic infection in a multicellular 
host 
Contrary to what has been described in TMV (González-
Jara et al., 2009) and CaMV (Gutiérrez et al., 2010), low rates of 
infection and coinfection were observed for TEV. Nevertheless, 
both infection and coinfection appear to increase over time in 
the different leaves reaching the 30% of infected cells and 10% 
of coinfection. Consequently, the predicted MOI values, which 
are extremely dependent of the estimation method, were low, 
ranging approximately from 1 to 1.65 viruses per cell. Our 
results should be consistent with previous study describing 
strong spatial separation pattern in mixed potyvirus infection 
(Dietrich and Maiss, 2003), limiting then the coinfection to “a 
small number of cells at the border of different fluorescent cell 
clusters”. However, our models incorporating spatial 
segregation of genotypes were never selected, and suggest that 
virus-infected cells are clearly aggregated. Moreover, the rate of 
mixed-genotype infection is higher than that expected at a 
given rate of infection for the Poisson null model. In other 
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words, our results contradict Dietrich and Maiss (2003) 
conclusions. The main difference between their experiment and 
our is on the scale of the study, we evaluated infection and 
coinfection at a cellular level, looking which of ca. 50000 viable 
protoplasts were non infected, infected or coinfected. 
Finally, low coinfection could be also an advantage for 
viral population, limiting cheating of complemented defective 
particles (Turner and Chao, 1998) or fitness reduction 
provocated by intrahost competition between viruses (Froissart 
et al., 2004). 
 
4. Evolution in case of genetic and functional 
redundancy in an RNA virus 
Dolja et al. (1993) tested for the first time the stability of 
TEV genome carrying a foreing gene by using a TEV-GUS 
engineered genotype. In this genotype, GUS gene is clearly 
useless for TEV. They studied the stability of the engineered 
genotype after two different infection periods. TEV-GUS 
weekly transfers from plant to plant showed a surprising 
retention of the GUS insert over 21 passages. However, one 
	   197	  
passage every four-weeks was enough to observe various large 
deletions including the sequences coding for most of GUS and 
of the N-terminal region of HC-Pro. In our experiment, we 
tested the genomic perturbation that occurs when TEV infects 
cells that are transgenically producing one of its essential genes, 
NIb. This study is especially relevant in the context of NIRVs, 
where no evolution study has been performed yet to 
understand the impact on the donor virus of having functional 
redundancy provided by the NIRV. In a first experiment, we 
made the hypothesis that if NIb is expressed by transgenic 
plant, then the viral NIb copy could be unnecessary for TEV 
and then could be deleted, as it was the case with GUS in Dolja 
et al. (1993) experiments. In a second experiment, we anticipate 
this deletion and study how a TEV-∆NIb evolves when trans-
complemented by the NIb protein expressed by the plants (i.e., 
NIb acts as a NIRV). Surprisingly, during short periods of 
infection i.e. 30 one-week passages, no multiple mutations were 
observed in both TEV and TEV-∆NIb genotypes. This result 
suggests that TEV genotypes showed a high stability and a 
capacity to evolve using NIb polymerase in trans.  Furthermore, 
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single mutations on the 6K1/CI proteolitic site, that should 
probably affect the NIa-Pro activity, were detected in TEV-
∆NIb. TEV is translated into a large polyprotein, thus a 
mechanism to regulate concentration of effective viral proteins 
in infected cells may be regulation of cleavage process (Merits 
et al., 2002). Most of these mutations showed a significant 
higher viral accumulation than the ancestral genotype. In 
conclusion, these mutations localized in the NIa-Pro substrate 
may positively regulate the cleavage 6K1/CI in order to 
produce more mature 6K1 and CI. Proteins NIb and CI are 
contituents of the viral replication complex (Carrington et al., 
1998), and thus increasing effective CI concentration may 
balance a lower production of NIb from the transgene in 
comparison to what should be produced by the virus in normal 
conditions. Furthermore, a single mutation in NIa-Pro was 
interestingly observed on most of TEV and TEV-∆NIb lineages. 
Mutants carrying this positively selected mutation showed a 
significantly higher viral accumulation than the ancestral 
genotypes. This mutation localized on the surface of the NIa-
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Pro may facilitate interactions between NIa-Pro and NIb, for 
example, or simply improve NIa-Pro binding to the substrate. 
During long period of infection, i.e. four three-week 
passages, NIb deletions were detected by RT-PCR and 
confirmed by NGS. We identified 22 different deletion variants, 
all conserving the reading frame. Twelve additional deletion 
variants, that must be defective particles, extended the deletion 
to a large part of 3’ NIa-Pro; six of them also had part of the 5’ 
extreme of CP deleted.  Interestingly, these various defective 
particles with no negligible frequency were able to colonize the 
host during infection being complemented with viable 
genotypes. As described in Montville et al. (2005), co-infection is 
a common viral strategy for RNA virus that is advantageous in 
the short term but prejudicial in the long term. Indeed, 
complementation can slow down the rate at which deleterious 
alleles are eliminated from the virus population (Froissart et al., 
2004) and promote selection for defective-interfering particles 
as cheater genotypes that reduce mean population fitness 
(Turner and Chao, 1999). 
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Finally, this experimental system allowed NIb deletion 
variants to be trans-complemented by the plant NIb NIRV and 
our results support our original hypothesis that the NIRV will 
relax selection on its homologous viral copy, making it 
redundant and, therefore, prescindible. Deleting viral NIb gene 
leads to a genome reduction size of about 15%, which could 
provide a replicative advantage to the deletion mutants. 
Recently, a direct competition study between TEV-GFP and 
TEV was performed (Zwart et al., unpublished data); TEV-GFP 
genome size is 7% larger that TEV. After only one three-week 
passage, TEV-GFP completely disappeared in all lineages to the 
benefit of TEV. 
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CONCLUSION 	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Along this thesis we have estimated two essential 
evolutionary parameters of TEV: the in vivo mutation and 
recombination rates. Interesingly, both rates are in the same 
range, which reflect the possibility that recombination and 
mutation are linked by the low fidelity and high processivity of 
viral RdRps (Simon-Loriere and Holmes, 2011): the faster the 
replicase moves, the less accuracy it is and the more likely to 
suffer a jump to a different template. Furthermore, as previous 
study (Jarvis and Kirkegaard, 1992), our results showed that a 
correlation exist between RNA concentration and 
recombination frequency in vivo. 
Nevertheless, an increase of recombination frequency 
was not observed between 15 and 45 dpi, suggesting that RNA 
concentration did not varied or had already reached a plateau. 
Moreover, recombination mechanisms are strongly dependent 
of coinfection, and then frequency of recombination should be 
closely related to MOI. Our results show that during host 
colonization and over time, TEV cellular MOI is quite low; so 
does the frequency of coinfection. These findings suggest that 
beyond what is minimally necessary (i.e., for each cell to be 
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infected with at least one of each virus), MOI has relatively 
little effect on recombination frequency, which is consistent 
with previous study on virus recombination (Kamita et al., 
2003). 
Finally, our result showed a great TEV genome 
plasticity under conditions of functional redundancy. Indeed, a 
large number of deletion variants, complemented in trans by 
NIb produced by the plant (NIRV), were observed indicating 
that non-homologous recombination can also occur during 
replication. Then, recombination should also act as a 
mechanism cleaning useless gene, generating quickly strong 
changes. 
Quasispecies theory predicts that the genome length, 
stably maintained without losing information, is negatively 
correlated with mutation rate (Eigen, 1971).  High processivity 
of viral RNA polymerase should be coupled with a high 
mutation rate, generating high genetic diversity, including 
variation in genome size. Coinfection favouring 
complementation should allow viral population to retain these 
size variants in the viral population. These variants composed 
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of viable and defective particles form a substantial part of the 
mutant swarm that may be important for evolvability. 
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